Myocardial infarction, without ST-elevation

I9_NSTEMI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I21.4 Cause of death: ICD-10 — I21.4 2 out of 7 registries used, show all original rules.	19915
4. Check minimum number of events None	19915
5. Include endpoints None	19915
6. Filter based on genotype QC (FinnGen only)	19339

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: I21
Name in latin: Infarctus subendocardialis acutus

NAME	I9_NSTEMI
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I214
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I214
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Myocardial infarction, without ST-elevation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	19339	6488	12851
Unadjusted period prevalence (%)	4.68	2.30	5.89
Median age at first event (years)	71.51	73.28	70.62

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
19915: Matched controls
181431

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.5

321.7

2211

8479

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.7

315.3

1897

6809

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.7

310.5

1047

2664

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

309.9

3014

13466

WX872

NOMESCO Finland

Intensive care

4.1

307.7

2076

4966

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

4.4

307.7

1691

3718

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

16498.4

307.7

9485

A10AE04

ATC

insulin glargine; parenteral

2.7

307.7

2863

10676

AN3

Balloon angioplasty and metallic stent

8.1

307.7

1856

2286

I20.09

ICD-10 Finland

Unstable angina

7.8

307.7

4050

5729

C08CA01

ATC

amlodipine; oral

1.9

307.7

9644

60573

I25.1

ICD-10 Finland

Atherosclerotic heart disease

11.6

307.7

14626

34986

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

5.0

307.7

3414

7257

R07.4

ICD-10 Finland

Chest pain, unspecified

3.0

307.7

8445

35990

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

3.2

307.7

1562

4740

Angiography of the heart and coronary arteries

3.8

307.7

3024

8107

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

10.6

307.7

475

417

C07AB02

ATC

metoprolol; systemic

2.1

307.7

5946

30724

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

9.9

307.7

1593

1575

AN1

Coronary angiography

6.3

307.7

6852

14030

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

10.1

307.7

726

676

C09AA05

ATC

ramipril; oral

3.3

307.7

9254

37846

A11

ICPC

Chest pain NOS

2.6

307.7

2228

8300

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.0

307.7

7532

30743

I50.0

ICD-10 Finland

Congestive heart failure

3.2

307.7

3436

11066

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

8.2

307.7

506

578

C01DA14

ATC

isosorbide mononitrate; oral

5.2

307.7

9052

24901

AA1

Conventional CABG

4.7

307.7

914

1822

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

12.6

307.7

933

706

ZXD05

NOMESCO Finland

Urgent procedure

3.5

307.7

9191

36012

A10AB05

ATC

insulin aspart; parenteral

2.8

307.7

2204

7712

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

5.1

307.7

5977

14081

I20.01

ICD-10 Finland

Unstable angina

7.8

307.7

2006

2580

Single vessel balloon catheter extension

5.9

307.7

1226

1995

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

9.9

307.7

438

411

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

11.9

307.7

13471

27017

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.9

307.7

1553

3878

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

421.2

307.7

1846

I20.00

ICD-10 Finland

Unstable angina

6.3

307.7

1837

2862

280

Kela drug reimbursment

Clopidogrel

9.3

307.7

1022

1047

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2524.0

307.7

4503

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

7.9

307.7

1881

2377

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.0

307.7

5936

31921

I50.1

ICD-10 Finland

Left ventricular failure

3.6

307.7

2213

6064

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.5

307.7

3103

12690

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

8.3

307.7

2674

3313

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

12.5

307.7

1267

979

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

8.9

307.7

4092

5098

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

307.7

5519

26934

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

5.9

307.7

2913

5143

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

5.3

307.7

901

1621

A10BA02

ATC

metformin; oral

1.8

307.7

7127

42098

ZXD00

NOMESCO Finland

Emergency procedure

4.6

307.7

1095

2249

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

13.2

307.7

5450

5024

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

5022.5

307.7

12659

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.4

307.7

3300

13862

K74

ICPC

Ischaemic heart dis with angina

5.9

307.7

620

991

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.0

307.7

3767

13055

C03DA01

ATC

spironolactone; oral

2.3

307.7

3622

16139

A02BC02

ATC

pantoprazole; systemic

2.1

307.7

14188

98923

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

3.2

307.7

8389

33501

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

7.8

307.7

13292

37319

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

307.7

7263

40102

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

5.7

307.7

909

1517

R06.0

ICD-10 Finland

Dyspnoea

1.9

307.7

6244

35144

I25

ICD-10 Finland

Chronic ischaemic heart disease

5.4

307.7

2717

5193

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

4.8

307.7

1071

2138

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.4

307.7

2185

6389

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

4.4

307.7

3872

9414

C03CA01

ATC

furosemide; systemic

2.8

307.7

10732

53617

AN2

Balloon angioplasty, including several vessels

6.3

307.7

1490

2298

I25.2

ICD-10 Finland

Old myocardial infarction

9.7

307.7

5770

7315

C07AB07

ATC

bisoprolol; oral

4.5

307.7

15391

78359

WX892

NOMESCO Finland

Monitored bed care

2.7

307.7

2208

8104

A10AC01

ATC

insulin (human); parenteral

2.8

307.7

2247

7971

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.6

307.7

6543

21668

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

8.2

307.7

3415

4473

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

307.7

6666

36301

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

307.7

4631

20730

C10AX09

ATC

ezetimibe; oral

3.8

307.7

5803

17616

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.0

307.7

6401

24836

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

5.6

307.7

2538

4630

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.8

307.7

3035

8183

C10AA05

ATC

atorvastatin; oral

3.6

307.7

13048

63199

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

7.2

307.7

1126

1490

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

4.4

307.7

4203

10302

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

307.7

6009

33099

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

5.9

307.7

1172

1911

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.8

307.7

2487

5286

B01AC04

ATC

clopidogrel; oral

7.5

307.7

10039

21749

B01AC24

ATC

ticagrelor; oral

29.9

307.7

4347

1677

AN4

Balloon angioplasty and drug eluding stent

9.8

307.7

2472

2576

I50.9

ICD-10 Finland

Heart failure, unspecified

3.2

307.7

6312

23141

I10

ICD-10 Finland

Essential (primary) hypertension

2.1

307.7

14711

103259

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

307.7

11887

68809

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

12.5

307.7

14247

30373

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

11.6

307.7

529

427

K76

ICPC

Ischaemic heart dis without angina

4.8

307.7

1191

2367

C10AA01

ATC

simvastatin; oral

2.4

307.7

12280

72059

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

306.5

2053

7768

Coronary artery bypass surgery

3.8

297.1

982

2463

C10AA07

ATC

rosuvastatin; oral

1.8

296.9

6707

40017

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

296.5

6705

40014

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

10.8

295.2

336

288

XF402

NOMESCO Finland

ECG with work load test

2.2

288.3

2828

12650

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

286.5

2849

12813

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

285.3

3860

19488

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

5.0

279.5

632

1179

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

5.0

276.7

626

1168

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

22.3

265.8

208

T90

ICPC

Diabetes non-insulin dependent

1.8

264.5

5726

33499

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4.4

259.0

679

1432

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

257.7

6522

39833

B01AC06

ATC

acetylsalicylic acid; oral

2.9

255.4

1319

4352

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

246.2

4843

27439

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.5

246.0

625

1285

I20.0

ICD-10 Finland

Unstable angina

6.3

237.7

417

611

A10AE05

ATC

insulin detemir; parenteral

2.7

237.4

1378

4833

FL1AC

NOMESCO Finland

Left cardioangiography

4.2

237.3

672

1504

205

Kela drug reimbursment

Chronic hypertension

1.7

236.8

7276

46555

K84

ICPC

Heart disease other

3.3

236.7

938

2647

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

4.8

234.7

560

1093

R4110

NOMESCO Finland

Physiotherapy

1.7

234.3

5639

33776

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

228.3

2390

10903

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.3

219.0

596

1293

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

216.3

1591

6250

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4.0

213.0

633

1468

207

Kela drug reimbursment

Chronic arrhythmias

1.8

210.7

4396

25168

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.5

210.2

754

1994

A10BB12

ATC

glimepiride; oral

2.2

208.7

2109

9470

R07.3

ICD-10 Finland

Other chest pain

2.1

208.2

2240

10304

I20.91

ICD-10 Finland

Angina pectoris, unspecified

4.4

208.0

548

1159

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

9.4

203.2

254

249

C10AA03

ATC

pravastatin; oral

2.2

201.1

1957

8651

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.0

197.9

589

1367

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.2

197.8

560

1252

ZXE00

NOMESCO Finland

One hour or less

1.6

194.3

7297

48420

A10BK03

ATC

empagliflozin; oral

2.0

191.3

2208

10408

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.7

190.6

462

913

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

4.0

189.1

568

1327

AP1

Catheterization of the left side of the heart

3.9

186.0

582

1400

A10AB01

ATC

insulin (human); parenteral

3.2

184.7

777

2271

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

184.7

1783

7846

AA1AD

NOMESCO Finland

CT of head and brain

1.6

184.5

6216

40083

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

183.3

1117

4003

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.2

182.4

1724

7520

FN2CD

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of vein graft

24.6

181.9

137

C10AA04

ATC

fluvastatin; oral

2.0

181.5

2352

11541

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

4.0

180.4

537

1246

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

6.8

180.4

296

404

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

8.6

179.6

240

257

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

179.4

1336

5264

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

176.1

2991

16017

A10BH05

ATC

linagliptin; oral

2.3

175.5

1466

6073

I21.48

ICD-10 Finland

Acute subendocardial infarction other occlusion in coronary artery

817.1

175.0

178

PE1AT

NOMESCO Finland

Femoral artery PTA

4.3

173.1

471

1021

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.2

171.3

264

336

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.3

170.9

692

1975

I20

ICD-10 Finland

Angina pectoris

3.9

170.6

536

1293

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

170.2

2832

15056

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

169.1

4343

26086

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

168.6

1016

3618

FN2EA

NOMESCO Finland

Coronary rotablation

9.0

165.0

213

218

A10AA02, ,

ATC

2.9

164.5

822

2652

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.5

164.4

1151

4405

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

5.2

164.0

352

626

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.1

163.3

1836

8547

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.0

162.9

1891

8905

B01AA03

ATC

warfarin; systemic

1.6

162.8

5319

33842

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

9.7

161.9

197

186

N02BE01

ATC

paracetamol; systemic, rectal

1.7

161.4

16894

138479

I21

ICD-10 Finland

Acute myocardial infarction

11.7

158.3

170

133

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

8.9

158.1

205

211

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.7

157.0

382

757

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.4

156.3

582

1575

A10AA01, ,

ATC

3.6

155.7

543

1407

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.1

154.0

663

1963

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.6

153.0

535

1389

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

153.0

5973

39460

M04AA01

ATC

allopurinol; systemic

1.7

150.4

3514

20511

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

149.7

2757

15064

A10AB04

ATC

insulin lispro; parenteral

3.2

149.3

624

1815

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.5

149.2

1008

3791

SPAT1262

SPAT

Handing over of treatment supplies

1.6

148.2

3890

23388

NHQ40

NOMESCO Finland

Amputation of toe

3.4

146.8

565

1561

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.3

146.7

1168

4730

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

146.2

3861

23238

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

145.7

5901

39203

N18.8

ICD-10 Finland

Other chronic renal failure

2.8

145.5

774

2582

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.6

144.9

491

1248

FXZ00

NOMESCO Finland

Off-pump cardiac operation

5.6

142.5

280

459

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.1

142.5

624

1866

TK800

NOMESCO Finland

Hemodialysis

3.2

141.1

581

1674

H3603, E103,

ICD-10 Finland

6.4

140.4

242

348

R53

ICD-10 Finland

Malaise and fatigue

1.6

139.7

4538

28657

R02

ICPC

Shortness of breath/dyspnoea

1.8

139.7

2668

14707

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

139.6

1295

5587

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.3

139.5

375

805

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.1

139.0

1436

6461

B01AF02

ATC

apixaban; oral

1.7

139.0

3172

18360

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.5

137.8

497

1317

PD5AD

NOMESCO Finland

CT of aorta

3.0

137.5

631

1939

XF404

NOMESCO Finland

Ambulatory ECG

1.9

137.4

1993

10101

A10BH01

ATC

sitagliptin; oral

1.8

136.9

2230

11722

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.4

135.8

968

3729

Multi-vessel balloon catheter extension

5.6

135.7

266

435

Z3231

NOMESCO Finland

Registered nurse

1.5

134.5

5341

35212

Z3226

NOMESCO Finland

Physiotherapist

1.6

134.1

3456

20619

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.8

133.6

710

2366

Z2221

NOMESCO Finland

Medical doctor

1.5

132.9

4838

31285

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

3.1

130.6

562

1663

SPAT1254

SPAT

Administration of medicine

1.7

130.4

3204

18875

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

130.3

3447

20683

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.0

130.0

600

1849

K75

ICPC

Acute myocardial infarction

8.8

130.0

170

177

A11CC03

ATC

alfacalcidol; systemic

2.9

129.4

624

1972

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

5.7

129.3

252

410

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.9

128.8

654

2126

N02AX02

ATC

tramadol; systemic, rectal

1.4

128.7

8369

60677

T89

ICPC

Diabetes insulin dependent

2.8

128.0

694

2337

I20.9

ICD-10 Finland

Angina pectoris, unspecified

3.7

127.4

424

1064

C10AX13

ATC

evolocumab; parenteral

8.0

127.0

179

205

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

2.8

126.2

648

2119

AA2

Off pump CABG sternotomy

6.2

125.1

221

326

C09AA02

ATC

enalapril; systemic

1.5

123.1

4617

29966

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

6.4

122.6

211

303

B01AC22

ATC

prasugrel; oral

7.5

122.1

182

223

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.3

121.9

484

1363

I50

ICD-10 Finland

Heart failure

2.3

118.8

964

3929

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

4.2

118.4

325

709

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

118.4

1680

8436

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.7

118.2

227

364

A10BB01

ATC

glibenclamide; oral

2.1

117.7

1258

5723

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.8

117.4

610

2007

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

117.3

7037

50010

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

5.6

117.0

229

374

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

116.9

2903

17102

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

4.5

116.3

294

601

A28

ICPC

Limited function/disability NOS

1.5

116.0

4113

26323

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.5

115.5

231

385

SPAT1097

SPAT

Recording of ECG

1.6

115.3

3131

18849

I47.2

ICD-10 Finland

Ventricular tachycardia

2.9

114.3

578

1874

111

Conventional CABG

4.3

114.3

305

651

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

113.1

7793

56667

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.5

112.8

401

1052

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

112.2

2972

17774

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.7

111.5

374

944

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

110.8

3021

18186

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

110.2

1340

6381

C08DB01

ATC

diltiazem; oral

1.9

110.1

1452

7109

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

109.7

6613

46884

S97

ICPC

Chronic ulcer skin

1.9

109.4

1453

7131

R07.2

ICD-10 Finland

Precordial pain

3.0

109.4

522

1639

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

109.3

4657

30911

287

Kela drug reimbursment

Ticagrelor 60 mg

42.7

108.5

J01DB01

ATC

cefalexin; oral

1.5

108.4

14825

120971

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.8

108.2

253

485

A10BK01

ATC

dapagliflozin; oral

1.9

108.0

1478

7326

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

107.8

2684

15794

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.9

107.7

548

1783

N19

ICD-10 Finland

Unspecified kidney failure

2.2

107.1

979

4189

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

106.4

993

4285

K01

ICPC

Heart pain

3.4

105.9

403

1105

C08CA13

ATC

lercanidipine; oral

1.6

105.5

3110

19050

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.6

105.3

369

959

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

105.3

3149

19353

C02AC05

ATC

moxonidine; oral

2.1

103.5

1106

5026

K77

ICPC

Heart failure

2.5

103.4

666

2443

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.4

103.1

382

1030

I21.42

ICD-10 Finland

Acute subendocardial infarction thrombus in coronary artery

+∞

102.6

102

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.6

102.5

648

2356

H3603, E113,

ICD-10 Finland

4.3

102.5

274

586

B01AC07

ATC

dipyridamole; systemic

1.9

101.4

1338

6547

315

Kela drug reimbursment

Clopidogrel

3.6

101.4

355

922

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.4

101.0

708

2702

A12AA04

ATC

calcium carbonate; oral

3.2

100.9

421

1222

H02AB06

ATC

prednisolone; systemic

1.4

100.0

8804

66247

C01BD01

ATC

amiodarone; systemic

2.3

99.7

775

3098

SPAT1263

SPAT

Sampling

1.4

99.7

7348

53695

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

4.9

99.2

226

424

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.6

99.0

241

478

A46

ICD-10 Finland

Erysipelas

1.5

98.4

3168

19762

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.4

97.1

197

333

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

96.8

2526

15004

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

3.7

96.6

312

767

250, ,

Kela drug reimbursment

3.2

96.0

396

1142

H3601, E113,

ICD-10 Finland

3.1

95.4

416

1240

I20.10

ICD-10 Finland

Angina angiospastic

5.8

95.4

180

284

Catheterization and pressure measurement of the left side of the heart

2.8

95.1

516

1737

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

92.6

1504

7854

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

6.2

92.5

165

246

A10AD05

ATC

insulin aspart; parenteral

2.7

92.5

531

1840

N03AX16

ATC

[U] pregabalin

1.5

92.5

4117

27422

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

92.3

2053

11707

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

91.8

3248

20647

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

2.9

91.8

454

1454

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

91.2

1631

8760

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

90.9

2526

15213

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.7

90.8

302

758

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

90.8

1925

10838

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

90.0

5419

38105

C08CA07

ATC

nisoldipine; oral

3.1

89.8

402

1217

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.6

89.7

302

764

M10.9

ICD-10 Finland

Gout, unspecified

1.7

89.7

1690

9212

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.4

89.6

231

480

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

2.8

87.5

448

1462

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

87.4

1198

5929

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

4.0

87.4

257

591

WX722

NOMESCO Finland

PEEP

2.0

86.9

994

4625

L28

ICPC

Limited function/disability (L)

1.5

86.9

3734

24661

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

86.7

841

3679

R55

ICD-10 Finland

Syncope and collapse

1.6

86.7

2427

14629

J01MA12

ATC

levofloxacin; systemic

1.5

86.6

3775

24999

C09DX04

ATC

valsartan and sacubitril; oral

3.7

86.2

289

729

E87.5

ICD-10 Finland

Hyperkalaemia

2.7

86.1

500

1743

C08CA02

ATC

felodipine; oral

1.6

85.8

2233

13228

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

85.7

800

3448

J01FF01

ATC

clindamycin; systemic

1.4

84.6

4622

31886

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.0

84.6

395

1225

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.6

84.2

293

758

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.3

84.1

334

941

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

3.6

84.1

286

729

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

84.0

996

4692

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

83.9

6503

47542

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

83.7

1934

11122

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.1

83.1

180

323

FN2EC

NOMESCO Finland

Transcatheter coronary thrombectomy

8.8

82.9

108

112

R42

ICD-10 Finland

Dizziness and giddiness

1.4

82.9

4440

30508

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

82.5

1756

9883

H36.01

ICD-10 Finland

Diabetic maculopathy

3.3

81.1

318

889

N18.0

ICD-10 Finland

End-stage renal disease

3.3

80.0

311

865

PEN23

NOMESCO Finland

Plastic repair of femoral artery

3.5

78.9

285

756

ANE

Coronary internal ultrasound (IVUS)

6.4

78.1

134

192

A04

ICPC

Weakness/tiredness general

1.5

77.9

2606

16318

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.6

77.8

261

659

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.9

77.8

1047

5146

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

4.3

77.2

207

444

V03AE01

ATC

polystyrene sulfonate; oral

3.0

76.6

354

1092

A10AE06

ATC

insulin degludec; parenteral

2.4

76.4

571

2242

I20.8

ICD-10 Finland

Other forms of angina pectoris

3.6

76.2

259

660

5315

FHL

Bypass surgery using a mammary artery

3.1

75.5

336

1014

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.7

74.0

239

588

V03AE03

ATC

lanthanum carbonate; oral

6.5

73.7

124

174

I51.4

ICD-10 Finland

Myocarditis, unspecified

5.9

73.7

136

210

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

73.2

962

4690

I22.99

ICD-10 Finland

Recurrent infarction with unspecified location unspecified coronary artery status

7.6

72.5

106

127

ZX120

NOMESCO Finland

Intravenous

1.6

72.4

1698

9782

SPAT1301

SPAT

No procedures

1.3

72.3

5756

42017

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

72.3

7452

56488

C08CA05

ATC

nifedipine; systemic

1.7

72.2

1401

7681

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

72.1

1463

8118

R2110

NOMESCO Finland

Giving the first information

1.9

71.8

927

4492

J81

ICD-10 Finland

Pulmonary oedema

4.3

71.6

191

408

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

3.5

70.5

246

638

B03XA02

ATC

darbepoetin alfa; parenteral

2.4

70.3

487

1848

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.0

70.0

833

3926

A10AD01

ATC

insulin (human); parenteral

2.6

70.0

419

1483

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.4

69.8

485

1843

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

69.6

892

4312

J01CA04

ATC

amoxicillin; systemic

1.3

69.4

13622

112496

PD3AT

NOMESCO Finland

Pelvic artery PTA

4.2

69.3

190

415

5314

FHL

Bypass surgery for four or more vessels

3.3

69.2

265

730

J01MA02

ATC

ciprofloxacin; systemic

1.3

69.2

7549

57569

C07AG02

ATC

carvedilol; oral

1.7

69.1

1338

7330

H3600, E103,

ICD-10 Finland

4.4

68.8

176

364

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.4

68.7

477

1812

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

68.6

2841

18534

K92

ICPC

Atherosclerosis/periph vascular dis

2.8

68.6

360

1191

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.1

68.6

291

854

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

4.3

68.2

183

393

R03BB04

ATC

tiotropium bromide; inhalant

1.5

68.0

2203

13671

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

67.9

3114

20708

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.2

67.8

581

2418

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

67.8

1137

5979

A12BA01

ATC

potassium chloride; oral

1.8

67.8

1128

5918

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.8

67.6

1029

5255

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

3.8

67.4

209

500

C09CA01

ATC

losartan; oral

1.4

67.1

4979

35874

V03AE02

ATC

sevelamer; oral

4.9

67.0

151

281

137

Kela drug reimbursment

Uraemia requiring dialysis

3.8

66.9

213

519

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.4

66.8

136

231

C02DE04, ,

ATC

2.0

66.8

714

3238

R11

ICD-10 Finland

Nausea and vomiting

1.7

66.7

1430

8047

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.1

66.7

709

3209

H3601, E103,

ICD-10 Finland

4.5

66.6

167

340

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.1

66.5

281

823

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

66.2

2111

13051

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

66.2

1299

7140

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.8

66.2

212

519

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

66.1

796

3767

1CX08, ,

NOMESCO Finland

5.0

66.0

145

264

SPAT1104

SPAT

Monitoring of emergency patient

1.7

65.8

1260

6879

WX213

NOMESCO Finland

Lower leg blockade

3.7

65.4

215

536

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

65.1

1704

10073

R03AC02

ATC

salbutamol; inhalant

1.3

64.6

8587

67027

Z49.2

ICD-10 Finland

Other dialysis

4.2

64.6

179

394

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

2.8

64.5

331

1082

H3600, E113,

ICD-10 Finland

2.8

64.1

328

1071

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.0

63.4

718

3325

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.3

63.3

244

675

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

63.3

1103

5862

5253

FHL

Cardiac lung machine

3.1

63.0

274

816

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

62.9

7910

61231

C03AA03

ATC

hydrochlorothiazide; oral

1.5

61.8

1959

12084

C10AA02

ATC

lovastatin; oral

1.8

61.8

982

5079

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

2.2

61.7

556

2361

R04.0

ICD-10 Finland

Epistaxis

1.6

61.4

1599

9434

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

4.6

61.0

151

304

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

3.8

60.8

189

453

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.8

60.5

1032

5450

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

60.5

5485

40575

WX890

NOMESCO Finland

Intesive care monitoring

3.6

60.5

209

539

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

59.7

3092

20960

I42.8

ICD-10 Finland

Other cardiomyopathies

4.7

59.6

142

277

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

59.4

1768

10751

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

59.4

5975

44810

K92.1

ICD-10 Finland

Melaena

1.7

59.2

1183

6529

WX720

NOMESCO Finland

Own respiration

1.9

59.0

815

4035

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.8

58.6

135

256

B05DA

ATC

Isotonic solutions

4.0

58.5

173

400

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

58.4

1492

8760

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

57.9

6513

49532

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

3.8

57.6

179

429

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

57.6

558

2438

PEC23

NOMESCO Finland

Suture of common femoral artery

4.9

57.0

129

241

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

56.8

2985

20269

M79.6

ICD-10 Finland

Pain in limb

1.3

56.6

6450

49099

K29

ICPC

Cardiovascular sympt/complt other

1.8

56.2

922

4813

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

55.9

415

1625

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

55.9

864

4431

C09CA03

ATC

valsartan; oral

1.5

55.7

1813

11235

K02

ICPC

Pressure/tightness of heart

2.2

55.6

466

1922

J01DA01

ATC

[U] cefalexin

1.3

55.6

10504

84999

I49.5

ICD-10 Finland

Sick sinus syndrome

1.8

55.4

924

4845

K22

ICPC

Risk factor cardiovascular disease

1.7

55.4

1118

6184

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.2

55.1

502

2141

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

4.0

54.9

161

370

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

3.8

54.9

174

423

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.0

54.8

636

2969

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

54.4

1993

12652

C09AA04

ATC

perindopril; oral

1.7

53.8

1080

5965

A41.9

ICD-10 Finland

Sepsis, unspecified

1.8

53.7

777

3903

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

53.5

679

3270

I24.1

ICD-10 Finland

Dressler syndrome

9.4

53.3

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

53.2

1885

11881

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.9

53.0

261

835

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.4

53.0

394

1544

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

52.9

1744

10830

B05DB

ATC

Hypertonic solutions

3.9

52.8

157

365

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

52.7

1435

8546

WX882

NOMESCO Finland

High dependency care

2.1

52.4

531

2360

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.2

52.2

474

2020

I25.40

ICD-10 Finland

Coronary artery aneurysm

14.4

51.5

A02BC01

ATC

omeprazole; systemic

1.3

51.3

4939

36666

N02AA05

ATC

oxycodone; systemic

1.3

51.1

3631

25823

A10BH02

ATC

vildagliptin; oral

2.2

51.0

452

1908

UJF32

NOMESCO Finland

Coloscopy

1.3

50.8

4800

35538

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

4.8

50.2

116

221

ANB

Coronary thrombectomy

5.7

50.2

154

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.4

50.0

129

269

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

50.0

2354

15653

R50.9

ICD-10 Finland

Fever, unspecified

1.4

49.9

2486

16696

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

49.7

2525

17009

4140B

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]

2.9

49.7

246

789

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

5.2

49.7

106

188

I20.08

ICD-10 Finland

Unstable angina

5.8

49.7

149

A02BC05

ATC

esomeprazole; systemic

1.3

49.6

6690

51770

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.2

49.5

444

1882

Z2446

NOMESCO Finland

Social worker

1.7

49.5

962

5266

FXG00

NOMESCO Finland

Insertion and use of IABP

5.8

49.3

144

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

49.3

1315

7791

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

49.2

2295

15233

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.9

49.1

236

745

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.8

48.9

722

3649

GD1LA

NOMESCO Finland

2.4

48.7

341

1301

WW502

NOMESCO Finland

Autotransfusion

3.5

48.4

168

435

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

48.3

1280

7571

I20.19

ICD-10 Finland

Angina angiospastic

4.6

48.3

117

232

M48.0

ICD-10 Finland

Spinal stenosis

1.4

48.2

2458

16564

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.7

48.1

259

870

WX002

NOMESCO Finland

Sedation and analgesia

1.3

47.9

3402

24168

H04AA01

ATC

glucagon; nasal, parenteral

2.8

47.8

251

832

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

5.0

47.8

106

195

A10BJ06

ATC

semaglutide; parenteral

1.8

47.7

709

3590

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

1.9

47.6

577

2736

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

3.5

47.4

168

441

TFN04, ,

NOMESCO Finland

3.7

47.4

156

390

S18

ICPC

Laceration/cut

1.2

47.2

8075

64118

SPAT1216

SPAT

Assessment of functional ability

1.4

47.1

3143

22112

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

2.6

46.7

268

930

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

46.7

860

4638

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

4.5

46.3

117

240

TK810

NOMESCO Finland

Hemofiltration

3.7

46.3

151

375

ZXA05

NOMESCO Finland

Left side

1.3

46.2

4561

33892

A06AD11

ATC

lactulose; oral

1.3

46.1

3163

22337

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

3.1

46.1

197

582

A02BC03

ATC

lansoprazole; oral

1.3

45.9

5036

37920

SPAT1252

SPAT

Overall medication plan or its review

1.5

45.6

1360

8259

ANA

Coronary roablation

7.6

45.3

PD4AD

NOMESCO Finland

CT of lower extremity arteries

3.1

45.2

194

574

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

45.2

847

4590

FNC50

NOMESCO Finland

Aorto-coronary venous bypass with five distal anastomoses

5.5

45.1

147

B04AB02, ,

ATC

2.0

44.8

486

2216

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

44.7

3015

21230

L17

ICPC

Foot/toe symptom/complaint

1.3

44.3

4583

34229

WX730

NOMESCO Finland

Conventional respirator

2.4

44.1

324

1264

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

2.9

44.0

208

651

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.9

43.8

534

2537

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.0

43.6

194

587

FNG10

NOMESCO Finland

Embolectomy of coronary artery

5.6

43.2

140

ZXA00

NOMESCO Finland

Right side

1.3

43.2

4854

36601

N06AX11

ATC

mirtazapine; oral

1.3

43.1

5270

40144

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

3.1

43.1

182

534

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.0

42.8

482

2227

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

3.5

42.5

147

380

3AC01, ,

NOMESCO Finland

3.0

42.4

191

582

E86

ICD-10 Finland

Volume depletion

1.9

42.3

551

2675

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

42.3

1205

7238

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.6

42.2

924

5214

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

5.5

42.2

140

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.5

42.1

149

391

I44.1

ICD-10 Finland

Atrioventricular block, second degree

1.9

42.1

508

2405

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

42.0

890

4982

I22.89

ICD-10 Finland

recurrent infarction with other location unspecified coronary artery status

18.8

41.6

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

41.6

605

3044

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

2.6

41.5

250

889

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

41.5

1222

7396

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

4.0

41.4

119

270

NFQ20

NOMESCO Finland

Amputation of femur

2.7

41.4

232

796

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.9

41.4

204

654

FN2EX

NOMESCO Finland

Other catheter-based coronary intervention

9.7

41.3

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.2

41.2

371

1577

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

2.5

40.9

261

955

K99

ICPC

Cardiovascular disease other

1.9

40.7

575

2866

I95.1

ICD-10 Finland

Orthostatic hypotension

1.7

40.7

854

4768

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

40.5

620

3169

C01AA05

ATC

digoxin; systemic

1.4

40.4

2024

13573

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

40.3

1141

6846

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.7

40.2

761

4134

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

39.9

719

3852

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

39.9

472

2220

N30.0

ICD-10 Finland

Acute cystitis

1.4

39.7

2361

16281

NGQ20

NOMESCO Finland

Amputation of lower leg

3.2

39.7

162

466

I70.0

ICD-10 Finland

Atherosclerosis of aorta

3.3

39.6

153

425

A02BA02

ATC

ranitidine; systemic

1.3

39.6

3534

25834

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

7.1

39.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

39.5

619

3185

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

4.9

39.5

166

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

39.4

6181

48325

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.1

39.4

388

1708

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

39.2

663

3490

296

Kela drug reimbursment

Rivaroxaban for the treatment of coronary heart disease

8.8

39.1

SPAT1310

SPAT

Counselling related to known health issue

1.3

39.1

5057

38687

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

39.1

1069

6361

ZPB22

NOMESCO Finland

Autograft of vein

3.3

39.0

152

425

SPAT1234

SPAT

Support of social functional capacity

1.6

38.9

1029

6077

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.8

38.9

195

631

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

38.9

2894

20632

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

2.9

38.8

181

563

SPAT1260

SPAT

Consultation of another employee

1.3

38.5

2907

20762

SPAT1255

SPAT

Intravenous administration of medicine

1.5

38.5

1207

7401

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

38.3

827

4649

SPAT1229

SPAT

Assessment of need for aid

1.5

38.3

1506

9664

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.7

38.3

818

4587

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

38.2

3561

26165

R60.0

ICD-10 Finland

Localized oedema

1.4

38.1

2209

15166

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

37.9

1347

8476

C07AB03

ATC

atenolol; systemic

1.5

37.9

1230

7598

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

37.8

1608

10471

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

37.6

4796

36601

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

37.4

3430

25143

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.7

37.3

710

3862

N03AX12

ATC

[U] gabapentin; oral

1.3

37.3

2510

17626

160

Kela drug reimbursment

exenatide

2.2

37.3

327

1376

I20.88

ICD-10 Finland

Other angina pectoris other occlusion in coronary artery

3.9

37.0

110

256

J01MA14

ATC

moxifloxacin; systemic

1.5

37.0

1474

9478

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11408

78282

1.77

316.80

6.0

6.3

12.35

12.39

umol/l

0.14

10882

74119

(3023368) Bacteria identified in Blood by Culture

8117

47211

1.96

307.65

5.3

4.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3425

15209

2.27

307.65

9.9

6.5

12.57

10.96

mmol/l

24.27

3249

14298

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4704

22276

2.21

307.65

3.6

2.5

19.37

22.19

40.31

4059

18639

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4278

19576

2.26

307.65

8.5

6.7

4.97

5.08

kpa

10.80

4050

18590

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5082

24954

2.15

307.65

2.4

2.0

31.00

30.04

18.10

4943

24196

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6999

40244

1.90

307.65

2.7

2.3

3.24

3.08

mg/l

4.51

6043

33865

(3027801) Oxygen [Partial pressure] in Arterial blood

4277

19561

2.26

307.65

8.5

6.7

11.34

11.96

kpa

13.32

4051

18561

(3016502) Oxygen saturation in Arterial blood

3926

17604

2.29

307.65

8.8

7.0

95.01

95.39

2.76

3769

16922

(3003396) Base excess in Arterial blood by calculation

4271

19566

2.26

307.65

8.5

6.7

0.89

1.11

mmol/l

2.62

3323

15546

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4885

23572

2.18

307.65

3.5

2.5

2.22

2.26

g/l

4.52

4548

21554

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

8290

48099

1.98

307.65

2.6

2.1

242.70

224.68

u/l

1.00

7777

44798

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3519

15932

2.23

307.65

9.4

7.5

119.02

121.07

g/l

6.84

3427

15491

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10136

51665

2.60

307.65

4.2

3.1

3014.10

1605.93

ng/l

67.23

9222

44554

(3022217) INR in Platelet poor plasma by Coagulation assay

12741

79031

2.30

307.65

20.8

18.9

1.40

1.37

inr

0.49

3515

21893

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

11026

61553

2.42

307.65

7.3

3.8

175.95

63.74

ng/l

4.01

9262

47370

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5450

29451

1.94

307.65

1.9

1.7

1.42

1.48

mg/l

0.55

4377

22948

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5383

27465

2.08

307.65

2.0

1.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7010

30974

2.64

307.65

7.8

3.6

946.10

434.70

ng/l

14.08

6634

26367

(3022948) Iron [Moles/volume] in Serum or Plasma

5130

25394

2.13

307.65

3.5

2.5

10.78

12.41

umol/l

51.73

4799

23324

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4588

14880

3.35

307.65

3.1

2.3

9.06

7.00

ug/l

6.49

4015

12632

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3474

15278

2.30

307.65

4.0

2.9

374.63

229.12

ng/l

28.55

3242

13982

(3013826) Glucose [Moles/volume] in Serum or Plasma

13477

89882

2.13

307.65

7.5

4.8

7.38

6.88

mmol/l

95.60

13012

84675

(3012544) pH of Venous blood

3429

16416

2.09

294.23

5.3

3.6

7.38

7.39

0.05

118

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8511

54712

1.73

287.86

3.8

2.8

160.66

170.35

ug/l

2.06

7802

49265

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3789

19005

2.01

285.27

1.9

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3783

18979

2.01

284.57

2.0

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1699

6174

2.65

274.11

3.2

2.7

0.34

0.35

u/ml

0.12

1059

3470

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4661

25377

1.88

273.75

3.3

3.2

0.81

mmol/l

0.26

4335

23481

(3014576) Chloride [Moles/volume] in Serum or Plasma

4076

21235

1.94

273.72

9.2

6.6

104.31

104.38

mmol/l

0.46

4069

21218

(3002032) Base excess in Venous blood by calculation

3270

15821

2.06

270.62

5.4

3.7

1.72

1.91

mmol/l

2.05

2765

13364

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3272

15858

2.05

269.41

5.3

3.6

5.81

5.83

kpa

0.60

3165

15390

(3014111) Lactate [Moles/volume] in Serum or Plasma

3079

14656

2.08

265.86

8.7

6.3

1.45

1.39

mmol/l

2.48

2989

14231

(3019060) Gas panel - Arterial blood

2581

11594

2.18

258.41

5.4

4.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4013

21206

1.91

256.16

8.5

5.5

1.10

1.03

mmol/l

41.41

3736

19479

(3000991) Gas panel - Venous blood

2903

13890

2.06

245.60

10.7

7.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

11090

78704

1.64

240.39

10.1

6.7

1.20

1.21

mmol/l

73.20

9548

66101

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2402

10773

2.17

240.34

8.3

6.9

24.14

24.62

mmol/l

7.79

2295

10249

(3004451) EKG impression Narrative

459

738

5.78

238.47

1.4

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2331

10616

2.13

223.30

10.9

8.2

0.66

0.46

2308

10542

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10173

71601

1.60

219.55

9.3

6.0

1.19

1.21

mmol/l

68.44

9382

64517

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2326

10652

2.12

219.42

10.6

8.1

1.35

1.36

0.28

2305

10572

(3024354) Oxygen [Partial pressure] in Venous blood

2688

13007

2.02

218.53

4.3

3.0

4.56

4.46

kpa

1.33

2594

12546

(3027945) Reticulocytes/100 erythrocytes in Blood

3738

20369

1.83

211.80

2.4

1.86

1.76

8.48

3296

17732

(3014007) Fractional oxyhemoglobin in Arterial blood

2296

10646

2.09

209.03

11.1

8.3

93.52

93.70

0.81

2278

10614

(3020682) Albumin/Creatinine [Ratio] in Urine

7704

51569

1.59

198.98

4.3

3.8

19.04

8.82

mg/mmol

30.33

5227

32980

(3012516) Albumin [Mass/volume] in Urine

7356

48707

1.60

198.97

3.6

3.3

349.60

403.40

mg/l

0.56

5186

31660

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1999

9069

2.12

191.83

11.9

9.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1967

9062

2.08

180.75

11.0

8.2

24.09

24.34

mmol/l

2.46

1858

8692

(3009508) Creatinine [Moles/volume] in Urine

7340

49365

1.56

180.74

3.5

3.2

6.99

7.53

mmol/l

24.94

6049

40598

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2045

9588

2.05

179.17

9.5

6.5

24.45

24.81

mmol/l

4.13

2028

9481

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9485

67814

1.52

174.55

3.2

2.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1831

8331

2.10

173.57

1.6

1.68

1.55

g/l

7.00

1584

7014

(3026008) Bacteria identified in Urine by Culture

7164

48322

1.55

171.69

3.8

3.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

14398

112910

1.58

171.21

8.7

7.7

83.87

80.78

u/l

8.03

13655

105686

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1420

5900

2.28

168.61

2.7

2.2

657.74

594.07

ug/l

0.28

1361

5562

(3004119) Hemoglobin [Mass/volume] in Venous blood

2121

10353

1.97

165.25

4.8

3.2

121.89

128.30

g/l

31.11

2047

10118

(3006315) Basophils [#/volume] in Blood

9702

70190

1.51

165.24

5.9

5.6

0.04

e9/l

1.35

8245

59809

(3013115) Eosinophils [#/volume] in Blood

9932

72269

1.50

164.01

6.1

5.8

0.21

0.20

e9/l

7.32

8557

62310

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2011

9684

1.99

162.75

1.6

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

9492

68493

1.50

162.74

6.0

4.8

33.59

34.63

g/l

54.62

8770

62985

(3001604) Monocytes [#/volume] in Blood

9656

69949

1.50

162.24

5.9

5.6

0.68

0.63

e9/l

18.20

8209

59585

(3019198) Lymphocytes [#/volume] in Blood

9835

71666

1.49

159.46

6.0

5.7

1.83

1.89

e9/l

1.57

8540

62366

(3023520) Reticulocytes [#/volume] in Blood

2834

15357

1.79

159.02

2.5

70.54

67.86

e9/l

3.68

2171

11751

(3044640) Blood type and Crossmatch panel - Blood

6970

47483

1.52

155.32

3.1

2.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1607

7271

2.10

153.83

2.0

1.9

2.23

2.24

ug/l

0.01

1414

6308

(3013650) Neutrophils [#/volume] in Blood by Automated count

10872

81207

1.48

153.24

8.2

8.9

4.83

4.32

e9/l

67.58

9379

70245

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2157

10848

1.91

153.18

4.7

3.6

5.13

5.14

kpa

0.10

2058

10175

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6440

43291

1.53

151.96

3.1

3.3

40.11

36.15

u/l

1.25

6051

40588

(3009343) pH of Capillary blood

2127

10723

1.90

149.75

4.7

3.6

7.42

0.13

335

1371

(3006504) Eosinophils/100 leukocytes in Blood

9100

65844

1.48

148.86

6.3

5.9

2.86

0.09

8488

60863

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

6903

47261

1.51

148.43

2.9

2.6

56.70

66.07

u/l

3.15

6433

43361

(3019069) Monocytes/100 leukocytes in Blood

9140

66225

1.48

148.24

6.6

6.3

8.94

0.02

8524

61289

(3031040) Bacteria [#/volume] in Urine by Automated count

12627

97529

1.49

147.85

5.9

4.9

1488.45

1478.46

e6/l

0.01

263

1630

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2065

10362

1.91

147.32

4.6

3.5

1.82

mmol/l

0.01

1534

7619

(3033658) Prothrombin time (PT) actual/Normal

5750

37920

1.54

147.22

5.2

4.1

81.72

84.25

11.68

5597

37068

(3022096) Basophils/100 leukocytes in Blood

8868

63930

1.48

147.20

6.3

6.0

0.62

0.65

5.00

8257

59047

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2069

10401

1.91

146.76

1.8

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3433

20074

1.67

145.42

3.5

4.1

250.47

247.76

u/l

0.43

3220

18864

(3002030) Lymphocytes/100 leukocytes in Blood

9253

67507

1.46

142.90

6.5

6.1

23.71

25.98

67.50

8627

62622

(3027273) Bicarbonate [Moles/volume] in Venous blood

1772

8541

1.98

142.11

4.9

3.4

24.88

25.18

mmol/l

2.89

1714

8305

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1650

7755

2.02

142.09

5.8

3.9

23.84

24.10

mmol/l

2.60

1597

7554

(3018010) Neutrophils/100 leukocytes in Blood

9113

66354

1.46

141.77

6.2

5.9

60.75

58.61

49.87

8501

61512

(3002582) Erythrocytes [#/volume] in Urine

7067

49073

1.48

139.39

4.1

3.5

80.81

116.40

e6/l

2.33

5647

38233

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

9124

66613

1.46

138.91

2.3

2.1

91.05

93.23

pmol/l

4.28

5011

35309

(3018405) Lactate [Moles/volume] in Arterial blood

1359

6020

2.13

136.95

4.8

4.0

1.47

1.39

mmol/l

1.43

1326

5913

(40760892) CBC W Ordered Manual Differential panel - Blood

9013

65792

1.45

136.43

6.7

6.3

—

(3018095) Leukocytes [#/volume] in Urine

7736

55018

1.46

133.28

4.6

3.9

137.57

118.68

e6/l

0.59

5935

40553

(3044889) 12 lead EKG panel

12948

101530

1.46

131.68

6.2

4.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2231

11906

1.80

129.86

1.7

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

5195

34259

1.52

129.71

1.9

1.8

1173.19

1159.61

nmol/l

0.45

3969

25382

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1517

7177

2.00

127.74

5.9

5.0

1.67

1.62

1.03

1424

6745

(3030467) Casts [#/volume] in Urine by Automated count

6481

44963

1.46

124.77

3.9

3.4

0.56

0.47

e6/l

1.21

5173

34867

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1631

7987

1.94

124.19

3.7

2.6

1.20

0.04

1622

7949

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

16632

137921

1.60

124.14

27.6

16.9

26.97

27.53

mg/l

1.43

14937

112881

(3026493) Urate [Moles/volume] in Serum or Plasma

5994

41059

1.47

122.71

3.3

2.9

4376.13

5905.27

umol/l

2.00

5137

35037

(3007930) Methemoglobin/Hemoglobin.total in Blood

1485

7077

1.99

122.31

6.0

5.1

0.89

0.87

1.30

1394

6643

(36304419) Bacteria [Presence] in Urine

6203

42853

1.46

121.21

3.9

3.3

—

(3020891) Body temperature

1431

6776

2.00

119.95

6.2

4.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5393

36324

1.48

119.59

3.0

2.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1599

7911

1.91

117.84

5.6

4.0

47.39

47.22

0.09

1581

7818

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1583

7822

1.92

117.07

3.7

2.6

0.66

0.65

0.51

1574

7791

(3043409) Potassium [Moles/volume] in Arterial blood

1165

5169

2.12

116.42

5.2

4.2

4.00

3.90

mmol/l

7.60

1148

5125

(3007853) Bacteria identified in Skin by Aerobe culture

2984

17762

1.62

115.07

2.3

1.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

929

3778

2.30

115.04

3.5

2.8

7.75

7.87

kpa

1.42

912

3692

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

15772

129914

1.51

113.65

8.8

6.4

44.24

40.79

mmol/mol

251.45

14770

117635

(3037467) Urinalysis macro (dipstick) panel - Urine

12662

100185

1.42

111.96

5.5

4.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

5673

39048

1.45

110.74

1.7

1.6

18.71

20.10

nmol/l

7.93

4961

32984

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1120

4997

2.10

110.17

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

5108

34549

1.47

108.89

3.3

2.7

4.57

4.53

e6/l

0.11

4635

30962

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1023

4433

2.16

108.46

4.0

3.0

24.64

24.76

mmol/l

0.36

1005

4339

(3018418) pH of Serum or Plasma

6548

46536

1.42

106.29

5.6

4.1

7.40

0.80

1313

8857

(3042936) Bacteria identified in Isolate by Culture

3537

22396

1.53

103.21

2.5

2.0

—

(3047181) Lactate [Moles/volume] in Blood

1128

5203

2.03

101.28

6.8

6.0

1.46

1.32

mmol/l

3.29

1006

4609

(3021901) Oxygen saturation in Capillary blood

802

3266

2.29

98.81

3.4

2.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

15435

127618

1.45

98.59

5.5

4.2

1.37

1.29

mmol/l

27.86

14299

113219

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2104

11955

1.67

96.11

5.4

3.7

130.82

95.81

ng/l

26.55

1808

10042

(1616796) Gas panel - Central venous blood

885

3825

2.16

94.24

4.9

3.7

—

(3010421) pH of Blood

968

4347

2.08

93.31

5.6

4.1

7.42

0.80

860

3961

(3022313) Gas panel - Capillary blood

1488

7739

1.81

92.86

4.9

3.7

—

(3024928) Oxygen saturation in Venous blood

800

3375

2.21

90.45

4.0

2.9

—

(40767503) Oxygen content in Capillary blood by calculation

838

3623

2.16

89.11

3.2

2.5

15.49

16.14

4.01

451

1917

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2681

16507

1.55

87.36

2.6

2.8

8.44

10.11

umol/l

4.20

2316

14460

(3018572) Chloride [Moles/volume] in Blood

838

3720

2.10

83.16

7.5

6.9

104.97

104.98

mmol/l

0.01

758

3341

(3039000) Anion gap in Blood

838

3720

2.10

83.16

7.5

6.9

11.67

11.22

mmol/l

3.46

758

3341

(3027315) Oxygen [Partial pressure] in Blood

857

3847

2.08

82.56

5.7

4.1

8.32

8.40

kpa

0.58

839

3739

(3012501) Base excess in Blood by calculation

852

3827

2.07

81.93

5.6

4.1

2.52

2.65

mmol/l

0.68

591

2630

(3013290) Carbon dioxide [Partial pressure] in Blood

852

3829

2.07

81.81

5.7

4.1

4.95

5.00

kpa

1.18

834

3722

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4095

27969

1.42

78.38

3.2

2.9

1.15

1.28

e6/l

0.53

2488

16351

(3020630) Protein [Mass/volume] in Serum or Plasma

2399

14741

1.55

78.20

2.3

2.6

65.39

66.15

g/l

5.27

2147

13221

(3026782) Osmolality of Urine

4752

33379

1.39

77.07

3.6

3.1

525.70

553.61

mosm/kgh2o

17.28

4150

28626

(3013512) EKG study

6411

47364

1.34

75.03

6.7

4.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

842

3888

2.02

75.01

2.3

3.62

3.65

g/l

0.24

807

3705

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15671

131917

1.39

72.50

6.1

4.7

1.26

1.42

mmol/l

307.65

14611

118244

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1224

6464

1.77

72.01

2.0

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2619

16666

1.50

71.99

5.0

3.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2180

13375

1.54

71.09

2.7

2.5

35.60

49.67

u/l

1.38

1818

11448

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1302

7025

1.74

71.05

2.1

2.0

—

(3028271) Lactate [Moles/volume] in Capillary blood

626

2673

2.17

68.56

2.3

1.9

1.71

1.74

mmol/l

0.25

613

2607

(3035350) Ketones [Presence] in Urine by Test strip

8970

70104

1.30

68.25

4.7

4.0

0.00

estimate

0.22

1815

14159

(3013707) Erythrocyte sedimentation rate by Westergren method

12718

104140

1.31

68.10

4.7

4.2

17.20

13.93

mm/h

70.38

11677

94883

(3022806) Fractional oxyhemoglobin in Capillary blood

531

2124

2.31

68.08

2.2

1.8

88.57

89.11

0.96

520

2094

(3009261) Glucose [Presence] in Urine by Test strip

9030

70710

1.30

67.37

4.8

4.0

0.00

estimate

2.35

1559

12708

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3788

26165

1.39

66.35

3.5

3.1

2.13

2.11

e6/l

0.04

2212

14648

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

15755

133292

1.37

65.83

6.2

4.7

3.84

4.47

mmol/l

307.65

14794

120437

(3021601) Nitrite [Presence] in Urine by Test strip

8909

69792

1.29

65.57

6.2

5.3

0.00

estimate

1.08

1696

13090

(3036489) Thrombin time

959

4885

1.83

63.48

2.1

1.9

22.68

21.89

1.59

882

4365

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

785

3759

1.94

62.91

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

785

3760

1.94

62.86

1.4

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

8422

65737

1.29

62.72

2.5

2.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12154

99409

1.29

62.64

4.0

3.8

15.08

15.07

pmol/l

0.28

10925

87945

(40758558) Short blood count panel - Blood

4928

35767

1.34

62.43

6.3

6.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

544

2292

2.19

61.59

6.6

6.1

12.20

12.05

mg/l

0.31

498

2074

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14740

123914

1.32

60.65

5.1

4.6

2.12

2.16

mu/l

0.37

13432

110416

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

726

3442

1.96

59.89

2.5

2.3

220.91

204.71

4.57

691

3258

(3006184) Hemoglobin [Mass/volume] in Capillary blood

798

3915

1.89

59.43

2.7

2.2

125.09

128.44

g/l

2.93

633

2822

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

847

4245

1.85

59.02

2.4

2.2

175.33

112.75

ug/min

2.78

519

2476

(3015736) pH of Urine

7302

56297

1.29

58.54

4.3

3.7

5.77

0.00

196

2489

(3004588) Protein electrophoresis panel - Serum or Plasma

1973

12327

1.51

58.43

2.1

2.4

—

(3021589) Normoblasts [#/volume] in Blood

7892

61542

1.28

57.45

13.7

10.4

0.00

e9/l

1.36

6349

50400

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1190

6646

1.67

56.87

5.4

3.9

24.61

24.85

mmol/l

1.83

1089

6035

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10375

83713

1.27

56.78

3.6

3.2

66.61

57.35

u/l

11.58

9523

76070

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

760

3779

1.87

54.25

1.5

1.6

—

(3019230) Fractional oxyhemoglobin in Venous blood

586

2673

2.03

53.91

3.7

2.5

66.85

63.02

3.66

581

2658

(3019550) Sodium [Moles/volume] in Serum or Plasma

16912

145769

1.38

53.84

35.0

19.9

139.32

139.58

mmol/l

30.41

16634

141812

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

16025

137081

1.33

52.83

7.0

5.3

2.08

2.60

mmol/l

307.65

15008

123303

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

756

3796

1.85

52.32

2.3

2.1

86.45

88.11

1.19

729

3640

(3011397) Hemoglobin [Presence] in Urine by Test strip

4626

33975

1.31

52.20

4.3

3.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1172

6663

1.64

52.16

1.4

1.5

17.60

16.65

u/ml

0.07

152

(3023103) Potassium [Moles/volume] in Serum or Plasma

16921

146032

1.37

51.83

35.3

20.1

4.05

4.00

mmol/l

97.88

16627

141851

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

727

3625

1.86

51.43

1.5

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

808

4172

1.80

51.03

1.5

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1069

6007

1.66

49.76

2.7

3.2

42.60

48.54

mg/l

0.93

831

4881

(3040151) Glucose [Moles/volume] in Capillary blood

461

1982

2.15

49.63

11.5

10.5

7.90

7.43

mmol/l

1.92

381

1614

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1882

12027

1.47

49.41

3.7

2.8

50.98

61.19

ml/min/173m2

27.11

914

5024

(3034860) Kappa light chains.free [Mass/volume] in Serum

1068

6014

1.65

49.30

2.7

3.2

117.43

66.17

mg/l

0.45

828

4883

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1042

5847

1.66

48.76

2.7

3.2

3.08

4.43

ratio

0.46

444

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7207

56440

1.26

47.74

2.4

2.2

75.58

79.13

nmol/l

20.57

6254

49077

(40760888) Immunoglobulin light chains.free panel - Serum

832

4491

1.72

44.99

2.7

3.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

149

375

3.64

44.82

10.3

7.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1719

10993

1.46

44.76

1.9

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4629

34580

1.29

44.70

1.8

1.7

41302452.70

26170137.03

pmol/l

0.79

3748

27742

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1757

11305

1.46

44.29

1.9

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

194

592

3.00

42.94

7.0

6.2

25.48

24.92

mmol/l

1.01

164

540

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2170

14650

1.39

41.68

2.0

2.2

0.20

g/l

2.83

1944

13487

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1797

11759

1.43

41.25

2.0

2.3

375.39

378.90

nmol/l

0.19

1633

10698

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15675

134829

1.28

41.07

6.1

5.1

6.48

6.10

mmol/l

141.95

14202

120097

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

509

2443

1.92

40.50

1.5

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

659

3451

1.77

39.65

2.1

2.5

30.65

33.62

umol/l

2.79

573

3047

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

558

2781

1.85

39.54

1.5

1.7

—

(40761535) Cells panel - Urine sediment

2034

13704

1.39

39.41

4.2

3.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

894

5129

1.62

38.19

1.7

1.6

205.26

269.40

titre

0.40

232

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

552

2773

1.84

38.14

1.5

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1945

13093

1.39

37.80

1.9

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

6544

51671

1.23

37.54

3.3

3.4

2.34

2.35

mmol/l

7.99

5590

44335

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

461

2205

1.93

37.08

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

13542

115064

1.23

36.57

31.7

19.9

15.52

15.40

1.54

13337

112752

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4717

36118

1.25

35.56

1.8

1.6

1.41

1.34

mmol/l

5.26

3977

29580

(3044242) Glucose [Moles/volume] in Arterial blood

223

816

2.51

34.99

1.8

2.0

—

(3019977) pH of Arterial blood

252

979

2.36

34.72

2.2

2.6

7.42

0.16

351

(3003434) Protein [Mass/volume] in Pleural fluid

547

2821

1.79

34.69

1.4

1.5

28.28

32.43

g/l

10.76

477

2530

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

450

2187

1.89

34.52

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

413

1967

1.93

33.68

2.4

1.39

1.17

g/24h

1.02

227

930

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

754

4283

1.63

33.52

1.4

7.61

15.34

iu/ml

2.23

102

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

358

1628

2.02

33.33

3.3

2.8

—

(40761511) CBC panel - Blood by Automated count

16206

140809

1.26

33.32

27.0

16.1

—

(3008037) Lactate [Moles/volume] in Venous blood

733

4146

1.63

33.15

4.9

3.3

1.66

mmol/l

0.03

715

4060

(3027456) Digoxin [Moles/volume] in Serum or Plasma

753

4295

1.62

32.92

3.2

0.83

0.81

nmol/l

0.86

573

3309

(3038071) Oxygen [Partial pressure] in Mixed venous blood

120

324

3.39

32.60

11.0

7.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

382

1805

1.95

31.91

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

446

2232

1.84

31.25

1.5

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

574

3094

1.71

31.21

1.3

1.2

75.56

167.19

titre

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

684

3865

1.63

31.06

3.5

2.7

2.18

1.69

mg/l

27.32

630

3451

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

655

3661

1.65

31.06

1.6

1.5

1.18

1.17

g/l

0.62

623

3452

(3052851) Hemolysis interference index of Serum or Plasma

827

4915

1.56

30.37

4.3

3.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

635

3548

1.65

30.15

1.6

1.5

0.24

g/l

1.44

602

3333

(3000012) Reticulocyte production index

519

2751

1.74

29.98

2.0

2.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

16692

145983

1.26

29.36

32.6

20.0

98.12

84.36

umol/l

148.89

16681

145914

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16646

145538

1.26

29.33

14.0

11.1

27.61

25.82

u/l

5.88

16092

139068

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

302

1354

2.05

29.29

1.6

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

585

3247

1.66

28.52

1.2

—

(3019150) Specific gravity of Urine by Refractometry

4069

31298

1.23

28.34

5.3

4.4

1.02

kg/l

0.58

712

4844

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

478

2533

1.74

27.67

5.5

3.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1192

7774

1.42

27.54

1.8

1.9

1.24

1.39

g/l

1.15

1069

6957

(3038515) Glucose [Moles/volume] in Venous blood

682

3966

1.59

27.53

5.2

3.4

8.17

7.74

mmol/l

2.99

666

3891

(3037522) Nuclear Ab [Titer] in Serum

2223

15975

1.30

27.42

1.3

527.41

498.46

titre

0.32

513

3435

(3022493) Free Hemoglobin [Mass/volume] in Plasma

177

655

2.47

27.24

6.1

3.8

111.69

1100.30

mg/l

1.01

130

444

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

465

2457

1.74

27.20

1.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

465

2457

1.74

27.20

1.4

1.6

—

(3022621) pH of Urine by Test strip

1446

9770

1.38

27.13

3.5

3.2

—

(3025941) Bacteria identified in Stool by Culture

1083

6970

1.44

26.91

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

470

2502

1.73

26.78

1.4

1.5

1865.76

2813.19

e6/l

0.74

353

1820

(40757494) Bilirubin.total [Moles/volume] in Blood

214

876

2.24

26.24

2.1

23.33

29.81

umol/l

0.37

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

365

1826

1.84

25.68

1.3

0.17

0.29

nmol/l

1.41

149

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

363

1821

1.83

25.32

1.3

3.58

1.61

nmol/l

0.30

347

1738

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

801

4919

1.50

25.28

1.9

1.7

—

(3017181) Myelocytes/100 leukocytes in Blood

1802

12727

1.32

25.13

3.9

0.85

0.96

1.35

715

4778

(3003338) MCHC [Mass/volume]

12793

109676

1.18

24.54

35.8

22.3

330.37

332.04

g/l

75.15

12625

108539

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

276

1280

1.98

24.45

1.2

1.3

1.45

1.42

nmol/l

0.22

251

1153

(40768797) Stomach Pathology biopsy report

2647

19703

1.26

24.41

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

337

1677

1.85

24.15

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6593

53680

1.18

24.08

5.3

4.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1642

11513

1.33

24.07

3.7

3.8

0.67

0.69

0.08

621

4088

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

494

2748

1.65

23.93

1.3

31.67

38.95

u/l

0.94

426

2358

(3051651) Icteric interference index of Serum or Plasma

218

935

2.14

23.86

5.0

3.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

1705

12045

1.32

23.68

3.9

0.08

0.11

1.17

627

4135

(3029937) Albumin [Presence] in Urine by Test strip

4897

38923

1.19

23.58

5.4

4.3

0.00

estimate

0.18

1511

12283

(3014051) Protein [Presence] in Urine by Test strip

640

3816

1.55

23.20

2.9

2.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1430

9905

1.34

22.76

2.5

2.7

10.60

10.74

g/l

0.53

1321

8993

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

969

6307

1.42

22.61

2.9

2.7

—

(3025159) Blasts/100 leukocytes in Blood

1599

11267

1.32

22.59

4.0

3.9

0.07

0.37

4.35

526

3408

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

998

6534

1.41

22.53

2.1

2.3

9.92

10.34

g/l

2.37

868

5676

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1058

7000

1.40

22.47

2.1

2.3

7.74

7.43

g/l

6.66

931

6197

(3007164) IgA [Mass/volume] in Serum or Plasma

2852

21594

1.24

22.42

1.5

2.87

2.73

g/l

2.14

1660

12398

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1756

12551

1.30

22.34

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1298

8893

1.35

22.20

2.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1053

6980

1.40

22.12

2.1

2.3

3.74

3.75

g/l

0.09

928

6184

(3035285) Chloride [Moles/volume] in Venous blood

446

2470

1.66

22.01

3.5

2.4

105.51

105.56

mmol/l

0.09

439

2451

(3041354) Potassium [Moles/volume] in Venous blood

446

2470

1.66

22.01

3.5

2.4

4.17

4.10

mmol/l

2.43

439

2452

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

261

3.15

21.96

7.6

6.8

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1054

6998

1.39

21.92

2.1

2.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

6.37

21.72

15.7

9.7

395.03

190.05

e6/l

0.41

(3017569) Oxygen content in Arterial blood

190

803

2.17

21.64

1.8

2.3

—

(3000330) Specific gravity of Urine by Test strip

1234

8428

1.36

21.54

4.3

3.9

—

(3037121) Protein [Mass/volume] in Urine

863

5552

1.43

21.48

3.0

0.47

0.31

g/l

3.63

412

2418

(3012441) Differential panel - Pleural fluid

400

2168

1.69

21.43

1.4

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

322

1645

1.80

21.24

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

322

1646

1.80

21.20

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

438

2440

1.65

21.15

3.5

2.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

416

2287

1.67

21.14

1.4

1.5

44229.65

62415.64

e6/l

0.83

264

1374

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

245

1154

1.95

20.83

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

241

1132

1.95

20.67

1.3

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

498

2883

1.59

20.57

1.4

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

14889

129879

1.18

20.51

25.8

16.2

68.83

73.99

ml/min/173m2

134.12

12882

108124

(3037756) Immunofixation for Serum or Plasma

654

4024

1.50

20.49

1.5

1.6

—

(3000492) Spirometry study

1630

11677

1.30

20.32

1.5

—

(3045414) Leukocytes [Presence] in Urine

953

6303

1.40

20.28

2.2

2.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

622

3802

1.51

20.12

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

221

1020

1.98

19.95

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

414

2312

1.64

19.83

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

622

3814

1.50

19.82

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.61

19.64

2.8

3.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

427

2413

1.63

19.51

1.4

—

(3017704) Immunofixation for Urine

215

992

1.99

19.44

1.3

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

614

3773

1.50

19.38

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

186

816

2.09

19.30

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

186

816

2.09

19.30

1.3

1.4

—

(3003181) Sodium [Moles/volume] in Urine

514

3045

1.55

19.24

1.4

1.3

58.75

61.93

mmol/l

1.25

416

2440

(3045788) Cell count panel - Pleural fluid

353

1910

1.70

19.09

1.4

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

16953

149801

1.21

18.98

40.5

24.8

38.53

39.84

63.69

15641

137743

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

308

1613

1.75

18.74

1.4

1.3

—

nmol/l

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

230

1101

1.91

18.70

1.6

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

539

3248

1.53

18.68

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

323

1718

1.72

18.60

4.4

3.4

—

(3042733) HLA Ab [Presence] in Serum

108

381

2.59

18.52

5.4

4.9

—

(3010813) Leukocytes [#/volume] in Blood

16959

149921

1.21

18.52

39.9

24.7

7.53

6.90

e9/l

106.52

16480

144491

(3035941) MCH [Entitic mass]

16954

149895

1.20

18.36

39.7

24.6

30.37

30.49

13.50

16707

146942

(3024731) MCV [Entitic volume]

16954

149913

1.20

18.23

39.7

24.6

91.83

91.69

3.22

16709

146956

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

966

6518

1.37

18.21

2.1

2.3

3.09

2.96

g/l

3.00

839

5717

(3007461) Platelets [#/volume] in Blood

16949

149867

1.20

18.21

39.9

24.7

235.92

238.51

e9/l

5.05

16532

145046

(3026361) Erythrocytes [#/volume] in Blood

16954

149918

1.20

18.19

39.9

24.7

4.31

4.44

e12/l

155.25

16470

144452

(3000963) Hemoglobin [Mass/volume] in Blood

16954

149939

1.20

18.04

40.2

24.9

129.81

134.50

g/l

240.52

16705

146989

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

410

2342

1.61

17.97

1.6

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

298

1567

1.74

17.90

1.2

57.70

64.17

u/l

0.99

272

1383

(21494890) Protein electrophoresis panel - 24 hour Urine

353

1950

1.66

17.69

1.7

2.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1813

13388

1.26

17.60

5.8

3.9

1.21

1.22

mmol/l

12.90

1629

11553

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

818

5402

1.40

17.58

2.0

2.2

36.22

37.15

g/l

4.20

689

4578

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

368

2060

1.64

17.52

1.6

1.4

127.50

118.05

u/ml

0.47

462

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

131

520

2.30

17.45

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

131

520

2.30

17.45

2.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

477

2845

1.54

17.36

1.8

1.5

0.90

0.83

nmol/l

1.00

379

2363

(3011985) Renin [Units/volume] in Plasma

333

1824

1.67

17.25

1.2

1.4

81.55

56.90

mu/l

1.32

296

1606

(3004775) Volume in Urine collected for unspecified duration

279

1461

1.75

17.03

2.3

2.2

691.68

676.77

0.22

183

957

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

402

2321

1.59

16.88

1.6

1.4

15.12

16.00

u/ml

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.96

16.87

5.1

2.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

337

1863

1.66

16.86

1.3

1.4

7.13

6.26

mmol/l

5.56

313

1719

(3023419) Bacteria identified in Sputum by Culture

444

2624

1.55

16.85

2.2

2.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

526

6965

0.68

16.56

2.0

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

181

835

1.98

16.46

1.6

1.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

877

5926

1.36

16.40

2.2

2.5

0.74

1.11

g/l

2.68

735

4959

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

983

6768

1.34

16.26

3.1

3.2

4.18

4.37

pmol/l

7.06

867

5902

(3016750) Collection duration of Urine

210

1025

1.88

16.17

2.2

2.1

500.03

497.59

min

0.12

145

740

(21494755) Public health laboratory ask at order entry panel

442

6020

0.66

16.09

1.5

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1030

7152

1.33

16.08

1.5

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

174

799

1.99

16.04

1.3

1.24

1.20

nmol/l

0.18

130

608

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3779

30212

1.17

15.98

3.0

3.2

2.47

2.46

mmol/l

1.86

3166

26225

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

620

3978

1.43

15.73

1.5

—

(3044927) Protein electrophoresis panel - Urine

338

1907

1.63

15.65

1.2

—

(40768806) Pleura Pathology biopsy report

377

2187

1.58

15.55

1.5

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

339

1920

1.62

15.46

1.3

1.2

310.73

288.10

u/ml

0.52

217

1193

(3026250) Tacrolimus [Mass/volume] in Blood

127

525

2.21

15.43

37.6

32.3

6.92

7.27

ug/l

1.05

116

461

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

358

2060

1.59

15.30

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

767

5136

1.37

15.20

2.1

2.3

0.02

0.04

g/l

0.73

696

4627

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

555

3526

1.45

14.87

1.8

13.66

11.69

mg/l

1.47

514

3239

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

719

4792

1.38

14.67

2.1

2.4

0.00

g/l

0.45

651

4302

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

707

4704

1.38

14.58

2.1

2.4

0.00

g/l

-0.00

646

4288

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

186

905

1.88

14.52

1.1

1.2

10.09

9.61

mmol/l

0.70

176

849

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

257

1378

1.71

14.50

1.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

257

1378

1.71

14.50

1.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

257

1378

1.71

14.50

1.3

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3055

24181

1.18

14.45

1.3

1.2

1.91

1.88

u/ml

0.03

726

5989

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

516

3256

1.46

14.35

1.4

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

339

1970

1.58

13.94

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

335

1944

1.58

13.86

1.3

399.54

491.40

u/l

0.32

315

1843

(3035947) Staphylolysin Ab [Units/volume] in Serum

162

766

1.93

13.81

1.2

1.1

2.80

4.11

iu/ml

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

707

4757

1.37

13.63

1.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.65

13.62

5.9

6.1

413.08

441.45

umol/l

0.29

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

190

952

1.83

13.56

1.7

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

189

953

1.81

13.23

1.7

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

198

3096

0.58

13.17

1.6

1.7

—

(40768446) Kidney Pathology biopsy report

116

497

2.13

12.98

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

419

2595

1.48

12.87

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

177

884

1.83

12.79

1.2

1.3

114.88

94.76

u/l

1.29

156

752

(3007566) Smooth muscle Ab [Titer] in Serum

512

3298

1.43

12.79

1.2

99.27

139.08

titre

0.53

282

(3042631) Mycobacterium sp identified in Specimen

414

2573

1.48

12.51

2.5

2.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

172

858

1.83

12.49

1.2

1.3

33.05

27.57

u/l

0.61

149

715

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

358

2160

1.52

12.49

2.5

2.1

20.81

28.59

mg/l

2.58

565

(3034770) Mitochondria Ab [Titer] in Serum

507

3284

1.42

12.30

1.2

786.92

864.88

titre

0.11

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

448

2840

1.45

12.23

5.3

5.2

2738.28

1252.83

iu/ml

0.29

449

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

130

595

2.00

12.23

1.7

2.0

91.42

94.97

0.54

125

565

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1243

9175

1.25

12.05

3.6

2.9

0.32

0.30

e6/l

0.30

1218

9026

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

801

5605

1.31

11.90

1.8

1.7

36.96

38.41

u/l

1.04

661

4775

(3041096) Erythrocytes [Presence] in Urine by Automated

4396

36203

1.14

11.80

4.7

3.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

293

1714

1.57

11.79

1.2

1.3

237.98

352.36

pmol/l

1.12

247

1438

(3014271) Vancomycin [Susceptibility]

213

1157

1.68

11.57

3.3

3.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2538

20181

1.17

11.14

13.0

8.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

440

2831

1.43

11.12

3.2

3.5

1.35

1.57

0.79

386

2457

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

259

1496

1.58

11.04

1.3

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

187

994

1.72

11.02

10.6

11.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

186

2.75

10.98

1.1

1.2

7.48

179739.38

nmol/l

0.72

148

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

317

1919

1.51

10.95

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

323

4325

0.68

10.90

1.6

1.5

—

(40762365) Oxygen content in Arterial blood by calculation

300

2.34

10.89

2.8

2.9

14.29

14.77

ml/dl

0.67

285

(3024522) Salmonella sp identified in Specimen by Organism specific culture

318

1933

1.51

10.78

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

167

867

1.76

10.70

2.5

2.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

323

1973

1.50

10.70

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

269

1587

1.55

10.48

1.3

1.7

—

(3014891) Appearance of Pleural fluid

306

2.30

10.43

1.2

1.3

—

(3012565) Volume of 24 hour Urine

150

762

1.80

10.36

2.2

1719.07

1891.07

1.25

129

647

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

174

927

1.72

10.21

1.6

8.64

7.04

u/l

0.44

144

734

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

618

4267

1.33

10.15

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

357

2.17

10.11

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

311

1912

1.49

10.02

1.4

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

295

2.29

9.97

1.7

1.6

124.85

111.11

ug/l

0.51

240

(3005988) Vibrio sp identified in Specimen by Organism specific culture

311

1915

1.49

9.95

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

310

1912

1.48

9.84

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

569

3900

1.34

9.83

1.1

—

(3003694) ABO and Rh group [Type] in Blood

4226

35072

1.12

9.74

1.3

—

(3019225) pH of Specimen

2070

16389

1.17

9.54

5.9

4.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

639

4477

1.31

9.48

1.4

251.04

258.45

ug/g

0.41

393

2726

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

174

948

1.68

9.44

1.1

1.2

—

(36660697) Celiac disease serology panel - Serum

1150

8657

1.22

9.32

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

1679

13113

1.18

9.15

2.0

2.1

195.62

163.71

ug/g

1.88

1342

10214

(3016038) Potassium [Moles/volume] in Urine

193

1090

1.62

9.12

1.2

1.1

37.44

34.62

mmol/l

0.73

163

905

(40768800) Prostate Pathology biopsy report

392

4905

0.72

9.06

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

5.09

8.98

7.7

10.7

—

(4200892) Spirometry reversibility

1379

10607

1.20

8.94

1.5

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

120

2.96

8.84

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

257

1571

1.50

8.59

1.2

3.68

3.79

u/ml

0.06

111

699

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

6.60

8.52

6.6

11.0

39.27

46.24

0.45

(3010375) cycloSPORINE [Mass/volume] in Blood

121

615

1.80

8.44

26.9

28.1

102.30

112.22

ug/l

1.23

519

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

521

3609

1.32

8.44

1.8

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

868

9690

0.81

8.40

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

278

1735

1.47

8.39

3.0

3.5

62.10

57.58

2.91

224

1434

(3005322) IgE [Units/volume] in Serum or Plasma

866

6417

1.24

8.19

1.4

1.3

295.14

266.04

u/ml

0.26

792

5882

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.45

8.12

27.4

13.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

108

537

1.84

8.11

1.5

1.6

80.14

104.52

umol/l

0.74

282

(40761536) Microorganisms panel - Urine sediment

1556

12213

1.17

7.99

5.5

4.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

307

1974

1.42

7.94

1.6

0.74

0.88

g/l

1.36

244

1471

(3035880) pH of Pleural fluid

196

1154

1.55

7.84

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

142

774

1.68

7.78

1.2

1.1

52.90

26.83

u/l

1.79

128

678

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

155

865

1.64

7.76

2.2

313.15

85.73

ug/min

0.88

210

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

211

2.34

7.72

2.3

2.7

90.79

86.72

mg/l

0.04

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

142

776

1.67

7.71

1.2

1.1

123.11

86.49

u/l

2.04

129

687

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

130

694

1.71

7.70

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

119

620

1.75

7.68

1.3

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

334

2194

1.39

7.66

2.5

316.78

5499.55

u/ml

0.81

150

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

206

1234

1.53

7.64

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

621

4471

1.27

7.56

1.4

—

(3006270) Folate [Moles/volume] in Blood

228

1402

1.49

7.47

1.3

1.2

302.40

328.34

nmol/l

1.08

169

1094

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

219

1338

1.50

7.41

1.6

20.97

27.33

u/ml

1.02

310

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

147

820

1.64

7.40

1.3

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

147

821

1.64

7.37

1.3

1.9

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

137

752

1.66

7.34

1.4

65.13

63.58

0.20

105

614

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

115

602

1.74

7.33

2.1

2.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

254

1608

1.44

7.19

1.2

2.90

3.93

u/ml

0.62

533

(40757373) Influenza virus identified in Isolate

351

1.98

7.17

1.4

1.5

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

493

1.81

7.15

1.3

1.4

17.76

22.24

1.00

410

(3024932) HLA-DR beta [Type]

385

1.92

7.04

1.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

291

1897

1.40

7.02

3.5

4.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

489

3450

1.30

7.01

4.7

3.6

28.03

30.07

mg/l

0.62

328

2261

(3023383) Lactate [Moles/volume] in Pleural fluid

120

648

1.69

6.87

1.2

1.3

3.12

3.53

mmol/l

0.68

107

595

(3015171) Extractable nuclear Ab [Units/volume] in Serum

600

4358

1.26

6.83

1.2

0.55

0.95

u/ml

0.75

407

(3000494) Fungus identified in Specimen by Culture

2055

16652

1.14

6.82

1.5

1.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

7.60

6.81

3.7

5.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

292

1930

1.38

6.53

1.0

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

439

3088

1.30

6.47

1.3

1.2

57.74

37.65

u/ml

0.74

166

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

612

4487

1.25

6.45

1.1

1.12

9.69

u/ml

0.90

(3035320) C reactive protein [Mass/volume] in Body fluid

170

1016

1.53

6.45

2.9

2.6

—

(3024471) HLA-A [Type]

398

1.86

6.41

1.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

416

2909

1.31

6.41

1.3

1.2

6.23

6.34

u/ml

0.02

482

(3042111) Morphology [Interpretation] in Bone marrow Narrative

422

2964

1.30

6.30

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

254

1651

1.41

6.28

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

515

3716

1.27

6.24

1.6

1.5

18.82

5.02

iu/ml

0.54

119

900

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

124

696

1.63

6.17

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

280

1861

1.38

6.08

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2439

20113

1.12

6.06

1.3

50.28

38.53

iu/ml

1.96

728

6271

(3033923) Metanephrine [Moles/time] in 24 hour Urine

284

1.99

6.05

1.2

1.1

0.71

0.67

umol/24h

0.18

133

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

159

2.35

6.04

1.1

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

433

1.79

6.02

1.6

1.9

166.02

178.83

0.64

402

(3034274) Bile acid [Moles/volume] in Serum --fasting

503

1.72

5.91

1.2

1.3

7.46

15.56

umol/l

2.26

350

(3014148) Varicella zoster virus Ab [Titer] in Serum

165

1000

1.51

5.91

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

157

942

1.52

5.89

1.3

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

175

1075

1.49

5.87

1.2

135.71

128.53

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

175

1075

1.49

5.87

1.2

158.39

135.25

titre

0.16

202

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

157

943

1.52

5.87

3.6

3.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

407

2876

1.30

5.84

1.3

1.2

8.47

6.26

u/ml

0.20

314

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

365

2549

1.31

5.73

1.2

13.71

9.22

u/ml

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

105

578

1.66

5.68

1.3

1.4

22.12

20.36

0.29

523

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

362

1.84

5.67

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

312

1.90

5.58

1.4

1.5

13.75

9.39

0.61

160

(3001893) Eosinophils/100 leukocytes in Pleural fluid

115

651

1.61

5.58

1.4

2.46

2.90

0.23

542

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

149

896

1.52

5.56

2.3

2.0

2.43

2.51

u/field

0.05

107

611

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

134

1851

0.66

5.53

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

179

1122

1.46

5.46

1.3

129.41

472.48

titre

2.29

121

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

111

627

1.62

5.44

4.5

2.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1074

0.56

5.38

1.4

128.44

172.23

pmol/l

2.47

1074

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

498

1.69

5.33

1.2

1.1

190.41

206.20

iu/ml

0.13

491

(3001019) Free T4 and TSH panel - Serum or Plasma

241

2976

0.73

5.30

1.7

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

534

3954

1.24

5.23

1.5

1.6

19836.92

15338.25

e6/l

1.11

380

2861

(3006462) Nitrate [Presence] in Urine

126

742

1.55

5.20

3.5

3.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

282

1930

1.34

5.15

1.1

793.67

510.68

iu/ml

0.14

374

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

172

2.17

5.09

4.5

4.7

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

196

2.09

5.09

1.0

1.5

—

10.85

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

348

2458

1.29

5.08

1.2

1.75

6.03

u/ml

2.21

199

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

240

1.98

5.04

1.3

1.4

80.92

71.60

1.83

199

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

259

1.94

5.04

1.3

31.44

335.12

u/l

1.03

186

(3049717) Cytology report of Urine Cyto stain

1025

8086

1.16

5.02

2.7

2.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

235

1571

1.37

5.01

1.3

12.07

13.76

u/l

0.40

204

1458

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8399

73572

1.07

5.00

4.8

5.3

3.38

3.88

ug/l

0.72

7388

65435

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1553

12625

1.13

4.93

1.7

1.8

1.65

1.58

2.06

1270

10635

(1761482) Bacteria [#/volume] in Urine by Culture

652

4961

1.20

4.90

5.3

4.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

218

1448

1.38

4.85

2.3

2.2

2.29

2.27

u/field

0.01

537

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

171

1089

1.43

4.85

1.4

1.3

80.91

63.79

titre

0.33

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

264

1809

1.33

4.81

3.3

3.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

251

1708

1.34

4.80

1.2

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2251

18729

1.11

4.74

1.2

14.79

15.39

u/ml

0.12

704

6577

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

228

1532

1.36

4.74

1.2

172.96

201.44

miu/ml

0.29

459

(3022145) Colonoscopy Study observation

1935

15973

1.11

4.73

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

107

623

1.57

4.69

1.1

1.2

—

(3021788) Differential panel - Synovial fluid

403

2932

1.26

4.67

1.4

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

369

2660

1.27

4.62

1.4

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

287

1.84

4.61

1.2

1.1

83.82

82.29

0.13

150

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

340

1.77

4.61

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

340

1.77

4.61

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

340

1.77

4.61

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

340

1.77

4.61

1.1

—

(4146454) Self-monitoring of blood glucose

284

1981

1.31

4.59

3.0

2.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

487

1.63

4.50

3.1

1.9

24.72

454.59

ug/l

1.23

456

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

323

1.78

4.48

1.3

—

(4062490) Immunoglobulin typing, IgG

188

1237

1.39

4.47

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

201

2.00

4.43

4.5

5.2

47.10

52.39

ug/min

0.26

176

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

293

2066

1.30

4.39

1.2

27.29

49.05

u/ml

1.97

210

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

357

2583

1.26

4.36

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

108

643

1.53

4.32

1.3

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

108

643

1.53

4.32

1.3

2.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

342

1.73

4.25

1.2

1.3

0.33

0.31

g/l

1.15

276

(3003129) Base excess in Capillary blood by calculation

460

1.63

4.23

1.5

1.8

-0.71

0.59

mmol/l

1.74

431

(3026692) Albumin [Mass/volume] in Peritoneal fluid

432

1.65

4.23

1.4

17.04

13.09

g/l

3.22

325

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

194

1297

1.37

4.21

1.1

1.78

2.08

iu/ml

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

350

1.72

4.21

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

325

1.74

4.12

1.1

1.3

113.98

112.35

0.17

285

(3027135) IgG subclass 1 [Mass/volume] in Serum

186

1240

1.37

4.12

1.4

6.84

7.06

g/l

0.36

144

836

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1248

12737

0.89

4.12

2.1

11.29

12.32

nmol/l

4.52

1067

11108

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

292

1.78

4.10

1.2

99.12

97.88

0.08

269

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

116

2.28

4.09

1.3

1.7

0.75

1.06

mmol/l

0.50

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

286

1.79

4.07

1.2

76.92

81.40

0.40

154

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

134

846

1.45

4.06

1.4

16.30

14.23

umol/l

1.84

123

790

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

108

653

1.51

4.05

1.4

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

260

1826

1.30

4.05

1.3

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

438

1.62

4.03

1.4

1.9

—

(3008295) Osmolality of Serum or Plasma

226

1559

1.32

4.01

1.5

1.3

277.76

277.24

mosm/kgh2o

0.12

172

1180

(3024139) IgG subclass 3 [Mass/volume] in Serum

185

1239

1.36

4.00

1.4

0.45

0.43

g/l

0.28

143

842

(44816559) Phosphatidylethanol [Mass/volume] in Blood

274

1942

1.29

3.99

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

185

1240

1.36

3.98

1.4

2.89

2.94

g/l

0.18

144

838

(3044941) Cell count panel - Synovial fluid

342

2494

1.25

3.95

1.3

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

215

1477

1.33

3.94

1.2

1.1

113.56

115.08

0.25

188

1315

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

158

1034

1.40

3.93

2.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

115

710

1.48

3.92

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

171

1135

1.38

3.91

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

358

1.68

3.90

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

115

711

1.48

3.89

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

142

914

1.42

3.89

2.2

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

152

992

1.40

3.85

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

305

1.73

3.84

1.4

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

158

1042

1.38

3.78

1.4

1.22

1.29

promille

0.21

120

801

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

221

1535

1.32

3.77

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

398

1.63

3.72

2.3

1.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

174

1169

1.36

3.72

1.5

1.3

27.07

24.51

iu/ml

0.25

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

506

1.55

3.69

1.5

1.6

4.22

9.84

nmol/l

0.64

442

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.52

3.68

1.2

14106.00

2178.80

ng/l

0.95

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

575

1.51

3.60

1.4

1.3

1.43

1.53

g/l

3.52

575

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

211

1468

1.31

3.58

1.4

14.28

13.19

u/l

1.48

204

1410

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

153

1015

1.38

3.55

1.2

18.57

3.26

u/ml

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

213

1.84

3.50

1.2

119.11

542.19

ng/l

0.57

141

(40768795) Lymph node Pathology biopsy report

111

1438

0.70

3.44

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

309

1.68

3.43

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

278

3156

0.80

3.37

2.4

1.6

4.52

4.01

mg/l

0.26

222

2351

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

203

1.84

3.35

1.2

76.06

80.90

0.32

(3003327) Ova and parasites identified in Stool by Light microscopy

461

3532

1.19

3.35

1.6

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

147

980

1.37

3.34

1.1

—

(3036603) Volume of Urine

149

996

1.37

3.33

1.5

1.6

1879.75

1853.75

0.15

142

955

(40768804) Tissue Pathology biopsy report

5920

56119

0.94

3.31

2.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

230

1640

1.28

3.28

1.4

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

239

1716

1.27

3.23

1.1

1.67

1.55

g/l

3.20

211

1532

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

501

1.51

3.23

2.0

1.7

128618.00

29785.24

u/ml

0.37

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

105

2.17

3.21

1.0

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

3.04

3.20

1.0

1.1

0.04

0.02

g/l

—

(3020961) Endomysium IgA Ab [Titer] in Serum

592

4652

1.16

3.19

1.1

230.62

218.55

titre

—

113

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

365

1.60

3.19

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

195

1367

1.30

3.18

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

103

652

1.44

3.17

1.5

1.8

3.95

844.46

u/l

1.06

197

(3042010) Triglyceride [Moles/volume] in Pleural fluid

275

1.69

3.15

1.3

0.26

1.29

mmol/l

2.87

176

(3039162) Centromere protein B Ab [Units/volume] in Serum

193

1353

1.30

3.15

1.2

57.25

49.30

u/ml

0.13

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

149

1007

1.35

3.13

2.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

166

1142

1.33

3.10

1.2

1.1

93.05

95.22

0.55

157

1049

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

442

0.49

3.10

11.5

12.4

886.87

824.57

nmol/l

0.28

415

(3006922) Hepatitis E virus Ab [Presence] in Serum

118

770

1.40

3.08

1.1

—

(21494434) Karyotype in Bone marrow

214

1526

1.28

3.07

1.1

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

220

1575

1.28

3.06

1.3

237124.67

143657.92

e6/l

0.79

151

1079

(3019832) Treponema pallidum Ab [Presence] in Serum

474

3673

1.18

3.06

1.5

1.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

203

1.80

3.05

1.3

1.2

64.63

73.82

0.77

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

260

1900

1.25

3.05

1.7

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

391

1.56

3.05

1.5

1.4

29.03

44.44

g/l

0.49

301

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

156

1067

1.33

3.04

1.2

88.57

78.61

u/ml

—

(4281824) Cell count and differential, peritoneal fluid

100

1284

0.71

3.00

1.3

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

156

1072

1.33

2.96

1.2

63.47

42.56

u/ml

0.56

(3037692) Legionella sp identified in Specimen by Organism specific culture

586

1.45

2.96

1.3

1.4

—

(3020491) Glucose [Moles/volume] in Blood

157

1082

1.32

2.92

2.4

2.0

7.83

7.28

mmol/l

1.27

108

730

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.28

2.89

1.5

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

193

1371

1.29

2.88

1.3

1.2

—

38.75

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

456

1.50

2.86

1.1

1.88

12.16

u/ml

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

376

1.55

2.85

1.2

1.35

1.52

mmol/l

0.42

232

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

330

2493

1.21

2.85

1.7

1.8

19.79

24.27

ug/l

1.53

319

2433

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

130

875

1.36

2.84

1.0

301.24

286.44

mg/l

1.30

117

778

(3047189) Immunofixation for 24 hour Urine

129

868

1.36

2.83

1.4

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

158

1096

1.32

2.83

1.2

40.11

52.31

u/ml

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

577

1.44

2.82

1.2

1.1

1.15

1.08

ratio

0.70

188

(3019420) Tryptase [Mass/volume] in Serum or Plasma

517

1.46

2.82

1.1

1.6

13.05

9.27

ug/l

0.36

476

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

372

1.54

2.76

2.5

7.85

7.62

mmol/l

0.21

231

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

439

1.50

2.73

1.8

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

128

867

1.35

2.71

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

128

868

1.35

2.69

1.5

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

430

4564

0.86

2.63

2.8

3.8

75.74

83.18

u/ml

0.18

410

4371

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

308

2332

1.21

2.63

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

110

736

1.36

2.54

1.6

1.5

9.78

6.17

u/l

1.08

601

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

209

1.70

2.53

2.9

3.0

0.38

0.40

u/field

0.04

209

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

217

1.68

2.49

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

547

1.42

2.48

1.1

1.2

38.95

40.37

g/l

0.40

285

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4427

42009

0.95

2.47

3.0

3.2

0.80

ug/l

0.04

3191

29585

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

465

1.45

2.45

1.3

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

105

2.00

2.45

3.1

4.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

346

2668

1.18

2.45

1.5

1.6

59.42

4.46

iu/l

0.81

115

797

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.25

2.41

8.9

9.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.19

2.41

3.0

1.3

23.35

23.61

mmol/l

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

122

838

1.33

2.40

3.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

206

1.68

2.38

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

119

1.92

2.38

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

271

2052

1.21

2.36

1.4

1.5

69.87

61.62

3.40

185

1294

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

193

1.70

2.35

1.1

1.2

74.78

114.31

ug/l

1.99

123

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

207

1.67

2.35

2.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

310

2384

1.19

2.29

1.1

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.09

2.28

1.2

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

180

1313

1.25

2.25

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

148

1.79

2.25

1.3

1.4

—

595.04

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

205

1.65

2.17

2.2

2.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

335

1.50

2.16

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

539

1.39

2.16

1.0

1.1

9.01

10.65

iu/ml

0.21

120

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

145

1669

0.79

2.13

3.2

3.5

27.47

40.32

u/ml

1.66

132

1619

(21491868) Cryoglobulin [Mass/volume] in Serum

465

1.41

2.11

1.3

1.2

0.05

0.66

g/l

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.21

2.07

1.0

150.25

175.77

pmol/l

—

(40762887) Creatinine [Moles/volume] in Blood

2.93

2.06

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

280

1.53

2.06

1.9

2.8

—

(3028707) Methadone [Presence] in Urine by Screen method

622

1.35

2.06

2.5

2.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

384

1.45

2.06

1.1

1857.20

1560.03

miu/ml

1.20

384

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

5.06

2.05

1.2

—

(3017732) Neutrophils [#/volume] in Blood

1117

9383

1.09

2.05

3.4

3.1

5.79

5.49

e9/l

0.29

819

7022

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.99

2.04

1.1

1.2

0.15

0.11

nmol/l

1.32

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

133

1.78

2.03

1.2

1.1

1.85

1.75

umol/24h

0.19

133

(3009871) Measles virus Ab [Titer] in Serum

290

1.51

1.99

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

183

1.64

1.95

1.8

2.4

—

(3026470) Cobalt [Mass/volume] in Blood

110

1289

0.78

1.91

1.9

5.16

3.67

ug/l

0.52

102

1175

(3005011) Chlamydia sp Ab [Titer] in Serum

136

1.74

1.90

1.9

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

617

1.33

1.87

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

207

1.59

1.86

1.7

1.6

42.48

53.38

pmol/l

0.49

167

(4035726) Immunohistochemistry procedure

1368

13333

0.93

1.85

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

209

1587

1.20

1.85

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2210

19108

1.06

1.84

5.8

4.8

33.13

32.78

0.77

1776

12481

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

348

1.44

1.84

1.2

395.03

280.05

pmol/l

0.42

248

(3002079) Sodium [Moles/time] in 24 hour Urine

573

1.34

1.81

1.2

142.49

171.09

mmol/24h

2.37

573

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

385

3076

1.14

1.81

1.8

1.7

—

(3045424) Erythrocytes [Presence] in Urine

311

2448

1.16

1.80

1.6

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.93

1.80

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

314

1.45

1.75

1.2

0.72

49.43

mg/l

1.26

249

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

624

1.32

1.75

1.3

183.00

269.29

ug/l

0.30

336

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

413

1.39

1.75

1.1

92.59

98.40

0.67

327

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

104

736

1.29

1.74

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

384

1.40

1.71

1.4

17.93

16.28

pmol/l

0.33

310

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

257

1.49

1.68

1.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

102

728

1.28

1.62

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

172

1.59

1.61

3.8

3.2

1.71

1.18

mg/l

0.88

133

(40759836) Histone Ab [Presence] in Serum by Immunoblot

111

802

1.26

1.60

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

111

804

1.26

1.58

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

111

804

1.26

1.58

1.2

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

344

2760

1.14

1.57

1.1

20.38

11.82

u/ml

0.34

212

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

957

0.77

1.56

3.6

5.2

44.16

97.04

u/ml

1.58

285

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

728

0.74

1.55

4.6

6.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

211

1.51

1.53

3.6

3.0

41.52

40.17

umol/l

0.13

171

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

111

808

1.25

1.52

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

222

1730

1.17

1.52

1.3

—

(3027874) Urate [Moles/volume] in Urine

2.10

1.52

1.1

1.66

1.59

mmol/l

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

111

809

1.25

1.51

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6587

58642

1.03

1.50

4.4

4.6

23.06

22.05

5.61

3320

30575

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

111

810

1.25

1.50

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.77

1.50

1.0

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.96

1.49

1.1

1.0

7.26

5.32

mmol/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

980

8317

1.08

1.48

1.2

—

(3025577) Chromium [Mass/volume] in Blood

111

1253

0.81

1.48

2.0

2.90

2.14

ug/l

0.50

1035

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

542

0.71

1.47

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

222

1.48

1.43

3.2

2.9

6.77

6.71

mg/l

0.02

179

(21494567) Legionella sp IgM Ab [Presence] in Serum

100

1.73

1.41

1.0

1.1

—

(40768793) Breast Pathology biopsy report

201

2135

0.86

1.40

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

583

1.28

1.39

2.0

2.2

49.17

55.32

umol/l

0.81

480

(3024263) Appearance of Synovial fluid

118

876

1.23

1.39

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

315

1.39

1.38

2.2

1.6

190.47

130.43

ng/l

1.26

315

(3022229) Phosphate [Moles/volume] in Urine

2.17

1.37

1.0

1.1

8.13

18.50

mmol/l

—

(40768443) Skin Pathology biopsy report

789

6670

1.08

1.35

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

188

1.50

1.34

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

130

1.61

1.34

1.6

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

419

1.33

1.34

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

123

1.63

1.33

1.9

2.1

11.15

15.59

0.58

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

1.33

0.0

1.3

—

361.69

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

531

1.29

1.33

2.1

1.9

13234.72

13574.13

e6/l

0.02

300

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.10

1.30

1.0

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

284

2285

1.13

1.30

1.8

3.93

4.84

mmol/24h

4.19

243

1933

(3039744) RNA polymerase III Ab [Units/volume] in Serum

103

1.68

1.29

1.1

—

5.75

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

158

0.52

1.29

1.2

1.6

—

(3028714) Urate [Moles/time] in 24 hour Urine

2.49

1.28

1.0

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.76

1.26

1.2

1.4

1.00

1.04

u/field

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.28

1.26

4.4

4.6

33.38

24.71

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

244

1.42

1.26

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.69

1.25

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

146

0.50

1.24

1.9

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

168

1306

1.17

1.24

1.7

1.8

5.14

4.25

mg/l

1.35

157

1232

(3025018) Bordetella pertussis Ab [Titer] in Serum

473

1.29

1.23

1.4

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.21

1.23

1.1

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

170

1.50

1.23

1.2

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

178

1.48

1.21

1.1

1.3

5.36

6.74

mmol/l

0.81

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

156

1.52

1.20

1.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

156

1.52

1.20

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

156

1.52

1.20

1.0

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

239

1.41

1.20

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

500

1.28

1.19

1.1

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

114

1.60

1.15

1.1

11.10

12.46

u/l

0.12

114

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

158

1.50

1.15

1.1

9.44

17.60

iu/ml

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

288

1.36

1.14

1.5

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.70

1.14

1.1

—

(3000285) Sodium [Moles/volume] in Blood

234

1.40

1.14

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

741

1.22

1.13

1.6

1.3

1.76

1.36

u/ml

0.22

443

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.02

1.13

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

611

1.24

1.11

2.3

2.0

2563.69

4096.59

e6/l

0.27

427

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

102

1119

0.83

1.10

1.0

44.56

43.32

ng/l

0.12

743

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

506

1.26

1.10

4.4

5.8

67.44

70.61

0.39

408

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

223

0.61

1.09

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.40

1.09

1.2

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

102

1116

0.83

1.08

1.0

720.12

699.55

ng/l

0.16

728

(3011288) Drugs identified in Urine by Screen method

107

813

1.20

1.06

4.3

2.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

184

1.44

1.06

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

641

0.78

1.05

1.6

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

114

0.48

1.05

1.2

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.95

1.03

1.1

1.0

—

(3002256) Pathology report gross observation

2052

19400

0.96

1.03

1.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.28

1.02

1.2

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1020

0.83

1.02

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

118

1.54

1.02

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

162

0.56

1.02

1.7

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1516

13221

1.05

1.01

1.3

—

(4034850) Laboratory test

560

4739

1.08

1.00

17.9

11.5

—

(3033799) Differential panel - Peritoneal fluid

546

1.24

1.00

2.2

1.8

—

(3042517) Benzodiazepines panel - Urine

1.86

0.99

2.0

1.4

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

157

1.45

0.97

2.2

66.24

59.57

0.48

104

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.82

0.97

1.0

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

329

1.30

0.97

1.1

1.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

476

1.24

0.95

1.3

1.4

15.79

24.66

umol/l

2.43

452

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

583

1.22

0.94

1.2

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

114

1.52

0.92

1.2

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.71

0.90

1.0

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

104

1113

0.85

0.90

1.0

303.89

334.70

ng/l

0.61

751

(3044007) Cell count panel - Peritoneal fluid

488

1.23

0.90

2.2

1.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

230

1.35

0.89

1.1

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

318

1.29

0.88

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

152

1212

1.14

0.88

1.1

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

522

1.22

0.88

2.7

2.9

30.03

28.96

umol/l

0.27

395

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.65

0.86

1.3

1.4

63.75

140.49

ug/l

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

392

3865

0.92

0.86

1.6

1.7

42.34

44.63

nmol/l

1.24

373

3707

(3008898) HLA-B27 [Presence]

260

2610

0.91

0.85

1.1

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

426

1.24

0.85

1.3

24.29

32.77

1.31

275

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.95

0.84

1.2

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

174

0.63

0.83

8.7

5.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.74

0.82

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

127

1007

1.15

0.82

1.2

2.29

2.23

mmol/l

0.24

108

940

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

226

1858

1.11

0.82

3.1

3.4

9.05

10.90

nmol/l

0.23

220

1814

(3036180) Methadone [Presence] in Urine

227

1.32

0.80

1.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

126

1.45

0.79

1.4

1.7

1.09

0.89

0.11

100

(3001729) Color of Synovial fluid

149

1.41

0.79

1.3

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

135

0.61

0.79

1.1

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

373

1.25

0.79

1.4

91.34

251.36

nmol/24h

0.96

373

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.66

0.78

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

277

1.28

0.76

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

458

1.21

0.75

1.1

—

(3016879) Cocaine [Presence] in Urine

151

1221

1.13

0.75

2.0

1.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

535

5179

0.94

0.74

1.3

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

287

1.27

0.73

1.4

1.3

15.40

25.12

1.50

221

(3030313) Adrenal Ab [Titer] in Serum

1.64

0.73

1.1

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

529

0.81

0.73

1.1

1.12

1.07

u/l

0.38

257

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

102

805

1.16

0.72

1.6

2.3

462.81

518.02

e6/l

0.60

689

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.56

0.72

1.0

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

729

1.16

0.72

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.50

0.72

1.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

403

1.22

0.71

1.5

—

(3022689) Creatine [Moles/volume] in Urine

437

1.21

0.70

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

344

0.77

0.70

1.8

2.5

140.54

135.25

nmol/l

0.10

298

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

314

1.25

0.69

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

185

1.33

0.69

2.0

1.6

54.26

46.01

umol/l

0.54

185

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

209

1.31

0.69

1.2

1.1

14.66

19.05

u/l

1.52

136

(3034426) Prothrombin time (PT)

372

1.23

0.69

1.3

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

455

1.20

0.69

1.3

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

742

0.85

0.68

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

162

1.35

0.68

1.8

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

126

1294

0.89

0.67

1.4

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

284

2392

1.08

0.66

1.3

1.4

11.71

9.32

u/l

1.44

211

1917

(3029396) Erythrocyte agglutination [Presence] in Blood

1.63

0.66

2.1

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

227

1.28

0.66

1.1

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

867

8248

0.96

0.65

2.3

2.4

22.72

24.90

au/ml

0.17

451

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

400

0.80

0.65

1.1

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

235

0.74

0.63

1.0

1.5

2.59

2.22

ug/l

0.28

126

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

213

1.28

0.62

1.0

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

528

1.17

0.62

1.4

75.13

59.05

4.71

450

(3045142) Bone marrow Pathology biopsy report

224

1875

1.09

0.61

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

238

1.26

0.61

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

123

999

1.12

0.61

2.1

1.8

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

6.5

—

0.35

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.60

0.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

455

0.82

0.59

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

127

1.36

0.58

1.3

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

411

3971

0.94

0.58

1.3

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

797

0.87

0.58

6.9

3.7

13.62

13.33

0.95

787

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

242

2040

1.08

0.58

2.3

2.5

834.93

780.58

u/ml

0.05

232

2012

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.71

0.57

4.5

3.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

782

7419

0.96

0.55

1.3

47.91

58.81

au/ml

0.65

418

(3000764) Benzodiazepines [Presence] in Urine

157

1302

1.10

0.55

1.9

1.7

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.52

0.54

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

187

0.73

0.54

1.1

1.2

—

79.26

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

605

1.14

0.53

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

252

1.23

0.52

1.1

1.0

0.44

0.22

u/ml

0.62

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.52

0.52

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

286

1.21

0.51

1.2

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

186

1562

1.09

0.51

3.4

3.0

131.70

44.22

mg/l

1.66

139

1149

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.48

0.50

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

155

1.29

0.50

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

641

0.87

0.50

1.2

1.4

0.17

nmol/l

0.02

471

(3027008) Opiates [Presence] in Urine

157

1310

1.09

0.50

1.9

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

227

1925

1.08

0.49

4.3

4.4

344.18

340.61

umol/l

0.14

190

1605

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

464

0.84

0.49

1.0

1.1

0.63

3.65

u/ml

—

(40762814) Titanium [Mass/volume] in Blood

355

0.82

0.49

2.3

2.2

2.94

3.64

ug/l

1.21

117

(3028300) Cannabinoids [Presence] in Urine

157

1313

1.09

0.48

1.9

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

740

1.12

0.48

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

222

1.23

0.48

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

313

0.81

0.47

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

149

1.28

0.46

15.6

9.2

—

(3027944) Amphetamines [Presence] in Urine

153

1281

1.09

0.46

1.9

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.37

0.46

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

358

1.17

0.45

1.4

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

179

1514

1.08

0.44

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

109

1091

0.91

0.43

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

669

1.12

0.42

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

774

0.89

0.42

1.5

3.73

3.98

0.06

175

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.13

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

152

1.26

0.41

2.9

2.7

—

(3011412) CD3 cells [#/volume] in Blood

146

1229

1.08

0.41

1.7

2.2

0.99

1.08

e9/l

0.88

133

1125

(3006245) CD3-CD19+ cells/100 cells in Blood

379

1.15

0.41

1.5

1.9

12.07

11.37

0.11

341

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

202

1.22

0.40

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

776

1.10

0.40

1.6

2.4

0.18

0.25

e9/l

3.21

690

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

448

1.14

0.40

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.37

0.40

1.0

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.39

0.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.69

0.39

1.1

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.69

0.39

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

228

1.20

0.39

1.5

1.9

1231.76

1679.82

e6/l

0.13

113

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

330

1.16

0.38

1.6

9.67

9.48

ug/l

0.12

330

(3015183) Erythrocyte sedimentation rate

383

0.86

0.38

1.1

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.34

0.38

1.7

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.38

0.38

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2020

18073

1.02

0.37

3.3

4.0

8.32

27.71

ug/l

10.94

1672

15125

(3021387) Prolactin [Units/volume] in Serum or Plasma

232

1997

1.06

0.37

1.7

1.8

314.79

288.20

mu/l

0.53

206

1860

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

381

0.86

0.36

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

174

0.79

0.36

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

119

1001

1.08

0.36

1.1

1.0

1.60

0.87

u/ml

0.44

391

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

147

1.24

0.36

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.44

0.35

1.2

1.4

356.27

594.22

nmol/l

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.44

0.35

1.8

1.4

—

(3019174) dRVVT (LA screen)

1.30

0.35

1.1

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

531

1.12

0.35

1.1

525.33

583.40

ng/l

0.07

147

(3050129) First trimester maternal screen panel - Serum or Plasma

113

0.73

0.35

1.4

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

149

1453

0.93

0.34

1.4

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

671

1.10

0.34

1.1

1.0

1.39

2.24

u/ml

0.70

254

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

362

3160

1.04

0.34

1.2

1.3

690.67

573.83

mg/l

0.65

334

3000

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

115

1.27

0.34

1.4

1.3

0.75

0.94

ml/s/173m2

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

107

1.28

0.34

1.1

0.90

1.10

u/field

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.33

0.33

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

224

1.18

0.33

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

404

1.13

0.33

1.8

2.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

560

0.89

0.33

1.2

6.12

6.22

mmol/l

0.36

522

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

131

0.76

0.32

1.1

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

183

1.20

0.32

1.1

1.0

0.48

1.12

u/ml

0.49

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

345

1.14

0.32

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

200

1.18

0.32

1.2

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

122

1035

1.07

0.31

1.1

1.0

3.15

2.86

u/ml

0.11

458

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

101

994

0.93

0.31

1.6

1.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.33

0.31

8.0

5.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.30

0.30

4.0

2.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

511

1.11

0.30

1.6

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

277

0.85

0.30

1.1

1.2

—

(4212803) Bone marrow aspirate examination

188

0.82

0.29

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.74

0.29

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.29

0.29

1.0

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

310

2713

1.04

0.28

1.3

14.43

25.24

e6/l

0.92

246

2110

(40765096) Chromosome analysis panel by Banding

496

0.90

0.28

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

323

1.13

0.28

1.6

1.5

0.49

0.39

ug/l

0.62

197

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

169

1.19

0.28

1.1

—

(3048879) Bone marrow aspiration report

584

1.09

0.28

1.3

1.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

751

1.08

0.28

1.4

1.9

16.44

15.42

nmol/l

0.72

693

(3020874) Milk IgE Ab [Units/volume] in Serum

332

1.13

0.27

1.1

1.0

0.33

0.88

u/ml

1.40

110

(44813793) Dust mix specific IgE antibody measurement

681

1.08

0.27

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

310

2718

1.04

0.27

1.3

1.4

436.73

2260.94

e6/l

1.54

259

2231

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.21

0.26

1.0

1.1

298.37

250.08

nmol/l

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

316

1.12

0.26

1.1

1.0

0.44

0.58

u/ml

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

166

0.82

0.26

1.0

6.87

7.96

u/ml

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

380

3579

0.97

0.26

1.3

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

315

2766

1.04

0.26

1.2

4.26

3.89

mmol/l

4.67

292

2591

(3028717) Thiamine [Mass/volume] in Blood

136

0.80

0.26

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

222

1.15

0.25

1.1

1.2

45.60

49.33

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

677

6020

1.03

0.25

1.1

1.2

121.84

122.62

iu/ml

0.02

238

2039

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

104

887

1.07

0.25

1.8

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

156

1349

1.05

0.25

1.3

1.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

165

0.83

0.25

9.9

7.9

0.57

0.44

umol/l

—

151

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

172

1.17

0.24

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

172

1.17

0.24

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

784

1.07

0.24

1.0

1.1

8.57

7.84

nmol/l

0.05

173

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.27

0.22

1.0

1.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.20

0.21

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

1.5

—

15.00

—

(3002523) Influenza virus A Ag [Presence] in Specimen

108

1040

0.95

0.21

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.17

0.21

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

183

1.15

0.21

1.4

2.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

129

1235

0.95

0.21

1.6

1.8

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

156

1359

1.05

0.20

1.2

7.97

7.91

mmol/l

0.08

130

1131

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

132

0.83

0.20

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

286

2524

1.03

0.20

1.2

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

795

0.94

0.20

2.2

2.7

35.66

36.32

0.12

449

(3045177) Copper [Moles/volume] in Urine

0.00

0.20

0.0

1.1

—

0.18

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.20

0.0

2.2

—

15.66

—

(3023410) Appearance of Cerebral spinal fluid

134

1165

1.05

0.19

1.5

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

394

3683

0.97

0.19

2.5

3.2

968.39

886.50

u/ml

0.08

350

3345

(1761868) Lipid panel - Serum or Plasma

4381

40168

0.99

0.18

4.2

3.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

140

0.85

0.18

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

573

5117

1.02

0.18

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.20

0.18

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

594

0.94

0.18

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.16

0.17

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

680

1.06

0.17

1.3

39.13

29.80

u/l

1.33

544

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

382

3399

1.02

0.17

1.2

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.76

0.17

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

215

0.89

0.16

4.7

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

573

0.94

0.16

1.1

1.2

63.29

57.25

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

726

1.05

0.16

1.1

1.0

3.85

2.78

u/ml

0.30

321

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.14

0.16

1.3

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

394

0.92

0.16

2.1

2.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

109

0.84

0.16

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

144

1.14

0.16

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

656

1.06

0.15

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

153

1.13

0.15

1.6

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.12

0.15

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

180

1.11

0.14

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.78

0.14

1.1

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

110

1043

0.96

0.14

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.18

0.14

1.7

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.82

0.13

1.5

1.8

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

652

0.95

0.13

4.3

5.4

36.10

466.17

u/ml

—

115

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

409

0.94

0.13

1.1

1.2

120.68

137.31

nmol/l

0.36

291

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

687

1.05

0.13

1.1

315.80

317.60

mg/l

0.03

605

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

732

1.05

0.13

1.1

40.52

45.13

mg/l

0.64

627

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

741

1.05

0.13

1.5

1.8

—

(40768441) Liver Pathology biopsy report

112

985

1.04

0.12

1.2

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

1.15

0.12

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

583

1.05

0.11

1.0

1.56

0.22

u/ml

0.51

184

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

124

0.88

0.11

1.1

1.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

106

935

1.03

0.10

1.7

1.9

73.70

69.77

2.07

100

886

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

478

1.05

0.10

1.8

1.9

—

(3024869) Neuronal Ab [Presence] in Serum

311

0.94

0.10

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

202

1.08

0.10

2.3

2.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.11

0.10

1.6

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

114

1.12

0.09

1.1

1.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

167

1.09

0.09

2.8

2.9

7.77

7.57

mmol/l

0.13

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.08

0.09

1.4

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.14

0.09

6.6

5.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

132

0.90

0.09

2.0

2.1

0.42

12.58

ug/l

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.13

0.09

1.2

1.1

95.87

84.89

ug/l

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

122

0.90

0.08

1.1

—

(40758358) Immune stain study

1.03

0.08

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.81

0.08

1.0

1.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.80

0.08

1.4

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.79

0.08

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.14

0.08

1.2

1.0

—

(3017509) Phencyclidine [Presence] in Urine

1.10

0.08

1.3

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.06

0.08

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

314

2823

1.01

0.07

1.7

1.9

192.20

194.79

pmol/l

0.17

293

2620

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

176

1574

1.02

0.07

1.5

17.93

27.69

4.62

117

998

(3045462) Protein/Creatinine [Ratio] in Urine

1.07

0.07

1.3

3.4

45.43

62.18

g/mol

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

384

1.04

0.07

1.1

1.2

16.60

25.72

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.86

0.07

1.0

1.3

269.71

353.65

umol/24h

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.87

0.06

1.6

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.85

0.06

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

296

1.05

0.06

1.1

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

314

1.04

0.06

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

379

0.96

0.06

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

684

6190

1.01

0.05

2.7

3.3

1869.90

1852.55

u/ml

0.01

558

5346

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

758

1.02

0.05

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

239

0.95

0.05

1.3

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

379

1.03

0.05

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

126

1166

0.98

0.04

1.1

11.72

4.17

u/ml

0.88

392

(3023323) Follitropin [Units/volume] in Serum or Plasma

184

1656

1.01

0.04

1.2

1.4

29.88

32.21

iu/l

0.43

151

1402

(3010726) Horse dander IgE Ab [Units/volume] in Serum

868

1.02

0.04

1.1

1.0

1.41

0.96

u/ml

0.37

428

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

155

0.94

0.04

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

475

0.98

0.03

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

319

0.97

0.03

1.3

1.9

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

374

0.97

0.03

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

338

1.02

0.02

1.1

—

(1002224) Polysomnography panel

424

3878

1.00

0.02

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

121

1.05

0.01

1.1

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

375

1.02

0.01

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

545

0.99

0.01

1.8

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

131

1202

0.99

0.01

1.2

1.1

2.82

1.17

u/ml

0.71

610

(40758292) HTLV I+II Ab panel - Serum

176

1.04

0.01

1.2

1.4

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

149

1.04

0.01

1.2

1.1

8.60

9.16

mg/g

0.13

141

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

195

1.03

0.00

1.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

414

1.01

0.00

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.95

0.00

1.1

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

181

1.01

0.00

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

163

1.01

0.00

2.4

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

367

0.99

0.00

6.1

6.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

103

934

1.00

0.00

1.8

2.4

700.23

584.10

e6/l

0.60

889

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

330

0.99

0.00

2.6

2.0

1.19

0.97

ug/l

0.30

311

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

360

0.99

0.00

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

143

1.02

0.00

1.9

3.1

36.80

175.15

ng/l

—

(37021550) Renin [Units/volume] in Plasma --upright

323

1.02

0.00

1.2

1.3

160.47

71.86

mu/l

1.12

230

(3016018) Differential panel - Cerebral spinal fluid

145

1317

1.00

0.00

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

489

1.01

0.00

1.3

1.5

26.69

29.21

umol/l

1.07

469

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

125

1.02

0.00

2.4

1.9

14.08

18.47

umol/l

1.28

125

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

359

0.99

0.00

1.1

—

(3013466) aPTT in Blood by Coagulation assay

0.98

0.00

1.2

1.1

40.00

39.87

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

32.75

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.91

0.00

3.0

2.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.3

—

2.21

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.5

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.8

—

3.40

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.95

-0.00

1.4

1.6

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.00

-0.00

2.2

2.5

—

(3035109) Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

-0.00

0.0

19.5

—

4.32

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.95

-0.00

1.0

1.1

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.93

-0.00

1.0

1.1

0.05

0.06

mg/l

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: I9_NSTEMI – Myocardial infarction, without ST-elevation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Myocardial infarction, without ST-elevation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Myocardial infarction, without ST-elevation (I9_NSTEMI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints